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Chapter 1
Introduction
1.1 Cancer of the larynx
The larynx anatomy is graphically presented in figure 1.1 . The vocal cords in the
center of the larynx are muscular bands covered by thin mucosa layers. Together,
the right and left vocal cords have a V-shape, when viewed from cranial. The vocal
cords play key roles in the control of the airflow during breathing, the protection
of airway, and in the production of sound for speech.
Cancer of the larynx is one of the most common cancers in Europe, with
about 52,000 new cases annually, 90% occurring in men. 95% of all cancers of the
larynx are squamous cell carcinomas [65]. Cancer of the larynx is mainly caused
by consumption of tobacco and alcohol. Nevertheless, tobacco dominates the risk
for cancer of the vocal cords. Over 90% of the present incidences of laryngeal
cancers could be prevented by avoiding smoking and alcohol consumption. The
most common symptoms observed in early glottic cancers are; the presence of
hoarseness, sore throat, shortness of breath, and the feeling of a lump in the
throat. Hoarseness, which is a an early symptom for glottic lesions, is the main
symptom which causes patients to seek medical consultation [65].
A complete ear, nose, and throat check (with mirrors and laryngscopes) and
histology examination are common steps in the examination of suspected laryngeal
cancer patients. Vocal cord mobility and exact tumor extension are carefully
assessed to aid specifying the exact stage (TNM staging) of the tumor [65]. The
stage of the tumor is important for establishing the treatment policy.
This thesis discusses treatment of early stage glottic cancers (Carcinoma in
situ (Tis), and tumors limited to one vocal cord (T1a), with no regional/distant
lymph node metastasis (N0M0)). Early stage glottic squamous cell carcinomas
(SCC) are usually confined to the glottic area. As the true vocal cords essentially
have no lymphatic vessels, these tumors are known to be highly localized [97]. It
is also known that these cancers are normally limited to the mucosa without the
involvement of the underlying muscles.
These early stage glottic tumors are frequently curable using one of the
treatment modalities; surgery, endoscopic laser surgery, and radiation therapy
(RT), which are equally successful in terms of local control [65, 105]. The
probability of cure is 80− 90% when using any of the above-mentioned treatment
modalities. Nevertheless, the treatment of choice of early glottic cancer is still
largely debated (surgery or radiotherapy). It is generally agreed that choice should
depend on the functional outcomes.
Comparative studies between endoscopic laser surgery and RT show no
differences between either treatment modalities except slightly better voice after
RT, which makes RT the favored treatment modality especially for invasive
carcinoma [102, 60].
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Figure 1.1: Anatomy of the larynx : schematic representation of the coronal(a),
transverse (b) and sagittal (c) planes at the level of the vocal cords.
1.2 Conventional radiotherapy treatment fields
Early glottic tumors treated with RT are conventionally irradiated using two
parallel opposed wedged 6-MV photon beams with field sizes that vary between
25 – 50cm2. The superior border of the treatment field is the hyoid bone and
the inferior border is the lower edge of the cricoid cartilage. The anterior border
is approximately 1cm outside the patient’s skin and the posterior border covers
∼ 1mm of the anterior vertebrae figure 1.2. These fields cover both vocal cords
and the surrounding muscles and cartilages conservatively. All the structures
receive the total prescribed dose (e.g. in our scheme 66Gy in 33 fractions).
Typical side effects of irradiating normal tissues with conventional RT
techniques are poor voice quality, persistent or progressive arytenoid edema, and
increased risk of strokes [20, 4, 104].
Considering current developments in the field of RT and the introduction of
image-guided radiotherapy (IGRT) techniques, using conventional conservative
irradiation techniques with large treatment fields is likely to be sub-optimal,
especially in case of a single involved vocal cord.
3
Chapter 1.
95%
80%
40%
20%
100%
Figure 1.2: Sagittal CT slice showing the iso-dose lines of conventional RT parallel
opposed fields (100%=66 Gy).
1.3 Single vocal cord irradiation - Outline of the
thesis
We have developed a new optimized radiotherapy technique to treat Tis and T1a
tumors confined to one vocal cord. The goal was to deliver a highly conformal dose
to the tumor, while minimizing radiation damage to the contra-lateral vocal cord
and other normal healthy tissues (e.g. surrounding cartilages, muscles, carotid
arteries, etc.) on both sides of the neck as much as possible.
Sparing the non-involved normal tissues with the new RT technique might
improve voice outcomes, preserve swallowing functionality, prevent arytenoid
edema, and reduce the risk of strokes in this group of patients. Moreover, for
laryngeal preservation, delivering a more conformal dose might allow re-irradiating
the tumors if the need arises in the future due to a regional recurrence or growth
of a second primary tumor in the same vicinity.
This thesis describes the steps we have taken to arrive at a highly focused,
image-guided radiation therapy (IGRT) technique for single vocal cord irradiation
for early glottic cancer patients. Chapter (2) covers the issue of internal organ
motion of the vocal cords with breathing. This was done with the aid of time-
resolved 4D computed tomography (4D-CT) scans of the region of the vocal cords
while monitoring the patient’s breathing signal. The extent of the movement of
the structures and the uncertainties involved were quantified and discussed in
details.
In chapter (3), the feasibility of using in-treatment-room cone beam computed
tomography scans (CBCT) for daily-on-line patient set-up corrections is discussed.
Guidelines for a fast automatic registration procedure are presented, and the
accuracy of this procedure was determined. The residual uncertainties in the
4
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position of the tumor after automatic registration were assessed and quantified.
Also a CTV-PTV safety margin was proposed to compensate for residual inter-
and intra-treatment set-up errors.
Single vocal cord irradiation (SVCI) with Intensity-modulated radiation
therapy (IMRT) for early glottic cancers is presented in chapter (4). An in-
house developed beam angle optimization algorithm was employed to find the
best beam orientations to deliver intensity modulated fluences (co-planar and
non-coplanar) with a maximum sparing of normal tissue and organs at risk.
These beam arrangements were then used in a Monte Carlo based (MC) treatment
planning system to generate IMRT plans. In Chapter (4) a comparison of plans
obtained using IMRT coplanar, IMRT non-coplanar, and conventional parallel
opposed wedged fields is presented. Moreover, a class-solution of five coplanar
beam angles is researched.
In chapter (5), the sensitivity of the IMRT plans for SVCI to geometrical
uncertainties resulting from patient’s set-up errors, respiration, and anatomical
variation/deformations was investigated. The effect of these uncertainties on dose
distribution in the CTV as well as the contra-lateral vocal cord sparing is reported.
In chapter (6), a review of the side effects that are commonly observed after
RT for the head and neck cancer is presented. The potential reduction of these
side effect with the introduction of SVCI as a standard treatment is discussed
based on a comparison of the dose received by different normal tissues. In
addition, the role of (hypo) fractionation in SVCI, considering the low probability
of normal tissue side-effects, is also discussed. A comparison of SVCI and carbon
dioxide endoscopic laser surgery in the management of early glottic cancers is also
discussed.
Chapter (7) presents a general discussion of the topics discussed in this thesis.
Early reports on the clinical implementation of IMRT for SVCI and proposals for
further research are also presented.
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Abstract
Background and Purpose: To quantify respiratory motion of the vocal cords
during normal respiration using 4D-CT. The final goal is to develop a technique
for single vocal cord irradiation (SVCI) in early glottic carcinoma. Sparing the
non-involved cord and surrounding structures has the potential to preserve voice
quality and allow re-irradiation of recurrent and second primary tumors.
Methods and Materials: Four-dimensional CTs of 1 mm slice thickness from
10 early glottic carcinoma patients were acquired. The lateral dimensions of the
air gap separating the vocal cords were measured anteriorly, at mid-level and
posteriorly at each phase of the 4D-CTs. The corresponding anterior-posterior
gaps were similarly measured. Cranio-caudal vocal cords movements during
breathing were derived from the shifts of the arythenoids.
Results: The population-averaged mean gap size ± the corresponding standard
deviation due to breathing (SDB) for the lateral gaps was 5.8±0.7mm anteriorly,
8.7± 0.9 mm at mid-level, and 11.0± 1.3mm posteriorly. Anterior-posterior gap
values were 21.7± 0.7mm, while cranio-caudal shift SDB was 0.8mm.
Conclusions: Vocal cords breathing motions were found to be small relative to
their separation. Hence, breathing motion does not seem to be a limiting factor
for SVCI.
4D-CT analysis of vocal cords mobility
2.1 Introduction
Early stage glottic carcinoma (EGC) is frequently curable using one of the
treatment modalities; surgery, laser surgery, and radiation therapy (RT), which
are equally successful in terms of local control and cure rates [65, 50, 10, 17,
105, 117, 136]. Speech and voice quality were reported to be significantly better
in patients treated with RT as opposed to surgery [60, 106]. Furthermore,
comparative studies between endoscopic laser surgery and RT show no differences
between either treatment modalities except slightly better voice after RT, which
makes RT the favoured treatment modality especially for invasive carcinoma
[50, 106, 102, 29, 68, 55]. The aim of the treatment is definite cure with a
probability of success that depends on the loco-regional extensions of the disease.
Using any of the above-mentioned treatment modalities T1 and T2 tumors have
80 − 90% probability of cure. Nevertheless, some groups reported that local
recurrences after RT for glottic lesions occurred in 5 − 20% of T1 tumors and
25 − 30% of T2 tumors [77, 114]. Once a tumor recurrence is confirmed by
histological examination it is usually treated surgically. Surgical treatment can
be either endoscopic laser surgery, partial or total laryngectomy [99, 84, 54]. In
this article, we consider the optimization of radiotherapy treatment of EGC, i.e.,
T1N0M0 and TisN0M0 according to the UICC classification.
Optimal treatment of laryngeal cancer demands both tumor eradication and
the preservation of the laryngeal function. Good results have been obtained with
radiotherapy for this group of patients in terms of local control rates, survival,
as well as voice quality [59]. However, voice quality following radiotherapy
could not be considered normal [20]. Verdonck-De Leeuw et al. [22] showed
that self-rated performance (questionnaires) and stroboscopic measurements are
highly correlated. Preliminary data obtained in our institute deduced from Voice
Handicap Index scores [76] (ongoing study, N = 122 patients with T1N0M0),
indicate that 22% of patients treated by radiotherapy alone ended up with poor
voice quality. Studies on the influence of voice deterioration on the quality of
life (QoL) showed that 27 − 58% of patients with voice problems experienced
difficulties in communication that disrupted their social lives [37, 95, 33, 122].
Dornfeld et al. investigated the dose to different laryngeal structures in relation to
complaints and found an inverse relationship between radiation doses and speech,
diet, as well as other QoL indicators after treatment [26]. These results underlined
the need to deliver lower doses to unnecessarily irradiated structures in order to
preserve the laryngeal function after RT.
In our clinic as well as most other institutes, the conventional RT technique
adopted for EGC is the use of two opposed lateral 6 MV photon beams with field
sizes that typically vary between 25 and 50 cm2 [15, 52]. The superior border of
the treatment field is the hyoid bone and the inferior border is the lower edge of
the cricoid cartilage. The anterior border is approximately 1 cm falloff and the
posterior border covers 1 mm of the anterior vertebrae [52]. Because these fields
cover the vocal cords and the surrounding muscles and cartilages so conservatively
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there have been attempts to deliver more conformal dose distributions [4, 69, 19].
Potentially this could lead to prevention of persistent or progressive arytenoid
edema, preservation of voice, and improvement of the quality of life for the RT
patients. No significant degradation in local control was observed when reducing
the treatment fields for arytenoid shielding [4, 69]. These results support the
use of smaller, highly focused treatment fields to irradiate only the affected vocal
cord, while sparing the surrounding structures as well as the healthy cord.
In our institute, we have embarked on a program for optimal conformality
in EGC, namely single vocal cord irradiation (SVCI). By thus sparing the non-
involved cord, we aim to improve the quality of voice and hence QoL of EGC
patients treated with RT while maintaining the very good local control rate that
is achieved with conventional radiotherapy. As a corollary, SVCI may allow re-
irradiation of recurrent tumors in cases of local failure as well as secondary primary
tumors in the vicinity and hence prevent laryngectomy for these cases.
Using 4D-CT and cone beam CTs, it is possible to take practical steps towards
SVCI. This paper addresses the issue of intra-fraction motion of the vocal cords
due to breathing using 4D-CT data. If breathing motion of the cords is relatively
large, for instance when compared to the opening between cords, SCVI might
require techniques such as breathing control or gating.
Single vocal cord irradiation requires precise techniques to visualize the cords
and to monitor the movements of the cords and the surrounding structures. It was
the purpose of this work to quantify the intra-fractional movements of the vocal
cords during normal breathing using 4D-CT. These motions may have clinical
consequences for the choice of margins around the clinical target volumes, i.e., in
the construction of the planning target volumes.
2.2 Methods and Materials
2.2.1 Patients and protocol
Ten patients with early glottic carcinoma were enrolled in this study after having
given informed consent. Patients and tumor characteristics are presented in Table
2.1.
In our clinic EGC patients undergo an outpatient examination performed by
both a head-and-neck surgeon and a radiation oncologist. For diagnostic-staging
purposes, patients are usually re-examined under anesthesia and a biopsy is taken.
In the majority of the cases contrast-enhanced CT scan is obtained to stage the
laryngeal tumor.
10
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Table 2.1: Patient characteristics
Patient Local tumor stage Right/left Age Sex
1 T1aN0M0 Left 68 M
2 T1aN0M0 Left 64 M
3 T1aN0M0 Left 52 M
4 cT1aN0Mxa Left 75 M
5 TisN0M0 Right 62 M
6 T1bN0M0 Left and right 55 M
7 T1aN0M0 Right 48 M
8 T1aN0Mx Left 67 M
9 T1aN0Mx Right 59 F
10 T1aN0M0 Right 69 M
a This patient was staged clinically, while all the other patients were staged
histologically
2.2.2 Immobilization, 4D-CT scan procedure and image recon-
struction
Instead of a conventional treatment simulator session to determine and mark
the treatment fields, patients included in this study were sent to the multi-slice
CT scanner (Siemens Medical Solutions, SOMATOM Sensation Open CT 40-
slices). They were immobilized using a thermoplastic mask with five fixation
points that is also used during treatment to reduce set-up uncertainties. 4D-CT
data sets were acquired using a high-resolution protocol with an acquisition slice
thickness of 1.5 mm. The reconstructed length was 12 cm and gantry rotation
time 0.5 s (pitch = 0.1). The respiratory signal was obtained from a pressure
sensor that is attached to an elastic belt (ANZAI medical; figure 2.1(a) and
(b)). Based on this signal, we divided the respiratory cycle into nine discrete
respiratory phases: start inhale, early inhale, mid inhale, late inhale, end inhale
(start exhale), early exhale, mid exhale, late exhale, and end exhale [133]. CT
data were retrospectively reconstructed for each phase of the respiratory cycle
with a reconstruction increment (slice thickness) of 1 mm. The reconstruction for
each phase bin was obtained by imaging four to five breathing cycles.
2.2.3 Measurements
The mobility of each patient’s vocal cords was quantified with the aid of the
virtual simulation software available with our scanner (VSIM syngo CT 2006A
from Siemens AG).
The lateral gap width (X) between the two vocal cords was measured in
three different positions along their length; (anterior) XANT , (middle) XMID,
11
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Figure 2.1: Acquisition of 4D-CTs and reconstruction (a) ANZAI belt with pressure
sensor. (b) The dashed rectangular structure represents the area scanned to acquire the
4D-CT. (c) Display of breathing signal in which the gray vertical bars indicates 0% inhale
(start insp).
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and (posterior) XPOST , see figure 2.2. The anterior-posterior gap width (Y)
between the anterior commissure and the midpoint between the arytenoids was
also measured. To provide a well-defined measurement of the cranial-caudal (Z)
movements of the vocal cords, we measured the position of the most cranial
extension of the arythenoids. In all measurements the start inspiration phase
(0% inhale) was taken as a reference.
(b) (c)
0
5
9
0
5
9
(a)
Anterior-
posterior gap
XANT
XMID
XPOST
Figure 2.2: (a) Axial view of the vocal cords and the different values measured with
breathing phase. (b and c) Sagittal and coronal images showing schematically the
different slices where the vocal cords are located. 0 mm corresponds to the most superior
and 9 mm to the most inferior slice.
2.3 Results
On average, the total time required for the 4D-CT procedure was 10 min.
The quality of the CTs allowed good visualization of the vocal cords and the
surrounding cartilage tissues especially in the transverse views of the CTs, see
[figure 2.2] and [figure 2.3].
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Figure 2.3: Transverse views showing middle inspiration phase (mid insp.) to the left
and the same slice at middle expiration phase to right for patients 4 and 7.
2.3.1 Variations in the magnitude of the different parameters
during respiration
In all the patients the vocal cords were visible in 7 − 10 transverse slices of 1
mm thickness. figure 2.4 shows an example of the different parameters that were
measured in 10 successive transverse slices in patient number 2 (Table 2.1). This
figure demonstrates how almost all slices show the same pattern of variation with
breathing phase in both the anterior-posterior and the lateral gaps. In the most
cranial slices the lateral gaps between the vocal cords were always larger than
those in the most caudal slices, reflecting the shape of the cords ((figure 2.2) and
(figure 2.4)).
Table 2.2 summarizes the observed intra-fractional movements of the different
parts of the vocal cords. The range, the mean magnitude, and the standard
deviation from the mean due to breathing of the lateral gaps between the left and
the right vocal cords and the anterior-posterior gaps (Y) were calculated from the
average values over all slices where the vocal cords were visible for each patient.
As shown in Table 2.2, the largest respiratory variations in the vocal cords gap
(SDB) were noticed posteriorly (XPOST ), where the mean gap values were also
the largest ((figure 2.2) and (figure 2.3)). Two of the 10 patients analyzed showed
negligible movements of the vocal cords in these lateral posterior gaps (SDB of
XPOST 0.5 mm), and in the remaining patients the standard deviations were in
the range of 0.7- 3.0 mm compared with mean XPOST gaps of 10.3 and 13.3 mm,
respectively.
From the statistics in Table 2.2, it becomes apparent that although there is
measurable breathing motion of the vocal cords, the intra-fraction variation in
the gap widths is small compared with the average gap width. Furthermore, the
14
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Figure 2.4: Measured vocal cords dimensions (figure 2.2) for patient 2 in 10 axial slices
with visible vocal cords, as a function of the respiration phase. 0 mm corresponds to the
most superior and 9 mm to the most inferior slice.
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Figure 2.5: For all patients, anterior-posterior gaps (Y) averaged over the slices with
visible vocal cords shown as a function of breathing phases.
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cranio-caudal motion has an average SDB < 1mm . The very limited observed
respiratory motion is also illustrated in [figures 2.5 and 2.6].
2.4 Discussion
We are developing a new irradiation technique to treat early glottic carcinoma.
Single vocal cord irradiation and sparing of the non-involved cord might help
preserving the voice. Our main concern is to safely irradiate a single vocal
cord with proper target coverage and simultaneously effectively spare the healthy
vocal cord and the surrounding tissues, muscles and cartilages. In cases of no
lymph node or anterior commissure involvement, the tumor volumes are usually
very localized. In addition, the vocal cords are well visible in CT images being
surrounded by the well-defined thyroid cartilage and the air gap which makes
it possible to define the CTV clearly. Apart from voice preservation, SVCI will
potentially allow re-irradiating recurrent tumors that are usually treated with
total or partial laryngectomy and more recently with laser surgery [99, 84, 54]. In
the treatment of recurrences the extent of the recurrent tumor after RT is difficult
to assess so the surgical margins are usually taken generously. Having the option
of re-irradiating these tumors might therefore improve the QoL and voice outcome
for these patients in comparison with surgical options.
As a first step in realizing SVCI, we have used 4D-CT to assess respiratory
vocal cord mobility. For each patient, vocal cord motion was measured using axial
CT slices with visible vocal cord (7 − 10 slices, depending on the patient, slice
thickness 1 mm). For patient 2, an overview of all obtained data is presented
in figure 2.4. This figure shows smooth curves with gradual changes when going
from one slice to the next (e.g., figure 2.4, upper left panel). Similar results were
obtained for all patients, underlining the validity of the applied 4D-CT procedure
for accurate motion measurement.
We have demonstrated that respiration induced intra-fraction motion of vocal
cords is small compared with the distance between the vocal cords. Maximum
displacements of the vocal cords were observed in the lateral direction towards the
back of the larynx (XPOST ). The patient-average SDB at this level was 1.3 mm
while the corresponding average lateral gap width was 11 mm (Table 2.2). The
SDB values in Table 2 are a measure of the relative displacement of both vocal
cords. Because of this, and because we did not correct for gap width measurement
inaccuracies, these SDB-values provide an overestimation of the lateral movement
of a single vocal cord during normal respiration. The cranial-caudal movements
of the cords are similarly small. The small respiratory cord mobility observed
implies that SVCI with substantial sparing of non-involved structures will not be
hampered by respiration. Moreover, feasibility of SVCI is unlikely to be enhanced
significantly by using respiratory motion compensation techniques such as active
breathing control [139], gating [51], or tumor tracking [113].
In an investigation of the laryngeal intra-fraction motion during radiotherapy,
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Figure 2.6: For each patient, lateral gaps (X) averaged over the axial slices with visible
vocal cords.
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van Asselen et al. [127] demonstrated that the incidence and total duration of
swallowing is small compared with the typical treatment time (10-20 min). They
conclude that it is not important to apply an internal margin to take these
swallowing displacements into account. Furthermore, because this infrequent
motion is also random, the impact on target coverage is small [123]. However,
swallowing induced motion during acquisition of the planning CT scan may
introduce significant systematic errors. Hence, swallowing must be prevented
during the acquisition of the planning CT scan.
To safely irradiate a single vocal cord, random intra-fraction errors caused
by internal organ motion, as well as other targeting errors must be controlled.
Apart from target definition uncertainties, two of the main remaining sources
of errors are (1) inter-fraction systematic and random positioning errors and (2)
dosimetric errors due to the application of very small treatment fields and the
air-tissue interface at the surface of the target volume. Obviously, these errors
must be minimized to allow optimal sparing of the non-involved cord without
loss of local control. To minimize both sources of error, we envision the following
procedure for the preparation and execution of treatment.
In the preparatory phase a 4D-CT is acquired for each patient, using the
methods described in this paper. Based on this 4D-CT scan, the average anatomy
and deformation due to breathing motion will be assessed on an individual
basis. Hence, although Table 2.2 describes the magnitude of variations to be
expected clinically, we will not use population-based statistics to describe vocal
cord motion. The results in this paper indicate typical SDB values of 1 mm.
When compared with the effective dosimetric margins that are already required
to compensate for the penumbra width (’block margin’), for most patients the
additional margin for these random motion errors is expected to be very small
[38]. Apart from the intra-fraction respiratory motion, additional random errors
will occur due to inaccuracies in the daily patient set-up. Because the latter errors
cannot be completely corrected for even with daily CT guidance (see below),
the relative contribution of the intra-fraction motion becomes even smaller.
Consequently, the purpose of the 4D-CT scan is to get a good definition of the
average anatomy to rule out systematic errors as well as to identify outliers in
the population that show large breathing motion (e.g., patient 10 in Table 2).
The CTV (vocal cord with tumor) in its average position will be expanded with
margins to take into account the small residue systematic and random errors.
Based on the average anatomy obtained from 4D-CT, a treatment plan will be
created using beam angle optimization [24].
It has been reported that incidences of local failure after RT might occur
due to the loss of electronic equilibrium at the air tissue interface that results
in underdosage of the tumor [120, 3, 94]. Therefore, caution must be applied to
prevent tumor underdosage. We will therefore calculate the dose in each breathing
phase of the 4D-CT data for SVCI patients using a Monte Carlo dose engine to
verify and, if necessary, adapt the treatment plans.
In daily treatment execution, cone beam CT (CB-CT) scans are already being
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obtained and on-line corrections will be applied. At present we are performing an
analysis of the accuracy of automatic (CT value based) registration for various
structures of interest to develop a valid on-line procedure for SVCI. This procedure
will be applied in combination with a system that is already in clinical use for
precise remote execution of on-line corrections driven by the imaging software
[81]. The results of this study on optimal on-line corrections for SVCI will be the
subject of a future paper.
2.5 Conclusions
The department of Radiation Oncology of the Erasmus Medical Center has
initiated a program to investigate single vocal cord irradiation, aiming at improved
voice quality, and also to allow re-irradiation. As a first step, for 10 patients the
vocal cord breathing motion was assessed using 4D-CT scans. Observed standard
deviations describing this motion around the mean position were generally
small (on average 1 mm) compared to the separation between the vocal cords.
Therefore, if 4D-CT is used to establish the average position of the cords and
their respiratory motion, planning margins required for internal cord motion are
small (<1 mm) compared to the average vocal cord opening. Consequently, single
vocal cord irradiation is not hampered by respiratory motion.
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Abstract
Background and Purpose: We are developing a technique for highly focused
vocal cord irradiation in early glottic carcinoma to optimally treat a target volume
confined to a single cord. This technique, in contrast with the conventional
methods, aims at sparing the healthy vocal cord. As such a technique requires sub-
mm daily targeting accuracy to be effective, we investigate the accuracy achievable
with on-line kV-cone beam CT (CBCT) corrections.
Methods and Materials: CBCT scans were obtained in 10 early glottic cancer
patients in each treatment fraction. The grey value registration available in X-
ray volume imaging (XVI) software (Elekta, Synergy) was applied to a volume of
interest encompassing the thyroid cartilage. After application of the thus derived
corrections, residue displacements with respect to the planning CT scan were
measured at clearly identifiable relevant landmarks. The intra- and inter-observer
variations were also measured.
Results: While before correction the systematic displacements of the vocal cords
were as large as 2.4 ± 3.3mm (cranial-caudal population mean ±SDΣ), daily
CBCT registration and correction reduced these values to less than 0.2± 0.5mm
in all directions. Random positioning errors (SD σ) were reduced to less than
1mm. Correcting only for translations and not for rotations did not appreciably
affect this accuracy. The residue random displacements partly stem from intra-
observer variations (SD = 0.2− 0.6mm).
Conclusions: The use of CBCT for daily image guidance in combination with
standard mask fixation reduced systematic and random set-up errors of the vocal
cords to < 1mm prior to the delivery of each fraction dose. Thus, this facilitates
the high targeting precision required for a single vocal cord irradiation.
On-line image-guidance for vocal cord tumor targeting
3.1 Introduction
Early stage glottic squamous cell carcinomas (SCCs) are usually confined to
the glottic area; as the true vocal cords essentially have no lymphatic vessels
these tumors are known to be highly localized [75, 138]. It is also known that
these cancers are normally limited to the mucosa without the involvement of
the underlying muscles due to the presence of Reinke’s space (superficial lamina
propria) [97]. It is a highly curable disease; therefore the aim of the treatment is to
cure with the best achievable functional results [56]. Radiotherapy is usually the
treatment of choice for these tumors [93]. Considering current developments in
the field of RT (e.g. IGRT techniques), using conventional conservative irradiation
techniques with large treatment fields is likely to be sub-optimal. At our institute
a new optimized radiotherapy technique to treat Tis and T1a tumors confined to
one vocal cord is under development. The goal is to deliver a highly conformal dose
to the tumor, with the clinical target volume (CTV) confined to one vocal cord,
while minimizing radiation damage to the other vocal cord and the surrounding
cartilages and muscles. We designate this highly focused irradiation technique
single vocal cord irradiation (SVCI). Our hypothesis is that maximally sparing
the non-involved vocal cord might improve voice outcomes after RT [1, 26].
In addition, Levendag et al. found a dose-effect relationship between dose to
swallowing muscles and dysphagia complaints [62]. In order to improve post
radiotherapy QoL, they recommended that precautions must be taken to limit
dose received by the swallowing muscles [62, 124]. Furthermore, for laryngeal
preservation, delivering a more conformal dose might allow re-irradiating the
tumors if the need arises in the future due to a regional recurrence or growth
of a second primary tumor in the same vicinity.
To maintain high tumor control probability in SVCI, a number of issues
regarding the dose delivery should be fully investigated and controlled, i.e. (1)
intra-fractional motion due to breathing and swallowing, (2) inter-fractional
position variations and (3) dosimetric accuracy of the highly localized dose
distributions. In an earlier investigation on issue (1), we found that respiration-
induced intra-fractional movements of the vocal cords are very small and do
not obstruct SVCI [93]. What is more, it was found that the incidence and
duration of swallowing were low in comparison with treatment times [127, 98].
However, swallowing must be prevented during planning CT acquisition to avoid
the introduction of large systematic errors. This paper addresses issue (2) using
kilo-voltage cone beam (CBCT) scans to track daily set-up variation in six
dimensions (three translational and three rotational) in prospectively enrolled
laryngeal cancer patients receiving conventional radiotherapy treatment. We
investigate and validate the use of the commercially available X-ray volume
imaging software (Elekta Synergy XVI release 3.5b147) for vocal cords positioning
and calculate the residual positioning errors after using automatic grey-value-
based registration of localization to reference planning CT scans and on-line
corrections. The goal is to quantify the residue systematic and random set-up
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errors, when an on-line correction protocol is used. These residual errors are used
to assess the safety margins needed around the CTV volumes from the statistics
of the population under study.
3.2 Methods and Materials
3.2.1 Patients
Ten patients receiving conventional treatment for glottic cancer were analyzed in
the context of this study after having given informed consents. For each patient,
a 3D planning CT scan was acquired using a multi-slice CT scanner (SOMATOM
Sensation Open, Siemens Medical Solutions) with 2.5 mm slice thickness. Patients
were instructed not to swallow during the CT acquisition as part of our scanning
protocol. The 3D planning CT image was then exported to the XVI system
to be used as a reference scan. These patients received doses of 66 Gy in 33
fractions using two laterally opposed photon beams on a 6MV linac (following
the conventional treatment protocol). During the course of treatment, patients
were immobilized using Posicast thermoplastic masks with five fixation points
(CIVCO medical solutions) that were also used during planning CT acquisition.
3.2.2 Imaging system, CBCT acquisition, and 3D matching
Before each treatment fraction, cone beam CT scans were acquired on an Elekta
Synergy treatment machine with an integrated kilo-voltage X-ray source. Using
the standard "head-and-neck" protocol (100 kV, 36.1 mAs), with gantry angles
−100◦ to +100◦ sets of 200 2D projections were acquired and 3D volumes were
constructed (1mm3 voxel size). A scan time of 1 min averaged out the small
breathing motion of the vocal cords in the CBCT [93]. The imaging dose from
each CBCT scan was measured to be approximately 1 mGy per scan (dose to the
skin at the level of the larynx). This low dose has a negligible contribution to the
patient dose compared to the treatment.
Although the image quality of the CBCT scans was inferior to that of the
planning CT, they showed sufficient contrast for this study, see figure 3.1 and
figure 3.2. A clipbox is defined around the thyroid cartilage containing the volume
of interest (VOI) in the planning CT. This is done once by an observer before
the start of the treatment fractions. Before each treatment fraction, the CBCT
is then automatically registered to the planning CT using the grey value match
function of the XVI software within, on average, 1 min. The registration is carried
out using only voxels that are inside the 3D volume, defined on the planning CT
scan by the alignment clipbox, based on a grey level correlation technique [46].
This method yields translations and rotations about the center of the alignment
clipbox prior to each treatment fraction. The results of the automatic registration
were always checked by an observer, visually verifying the matching quality of
24
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Figure 3.1: Determination of the residual error in the position of the left arytenoid
(indicated by the circle) after XVI automatic grey value matching. Each window shows
a cut view of the localization and the reference CT scans.
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the bony structures (cartilages) inside and outside the VOI that is defined by
the clipbox using checkerboard overlays. The positioning errors before applying
registration-based positional corrections (i.e. initial set-up errors) are reported.
Figure 3.2: Determination of the residual error on the position of the front node of the
thyroid cartilage (indicated by the circle) after XVI automatic grey value matching and
applying the translation only automatically derived correction (given by table correction
values in the right lower panel).
3.2.3 Accuracy achievable with CBCT on-line corrections
The translations and rotations obtained from the matches described above were
applied to the CBCT scan. It is then possible to check point-by-point the
coincidence of anatomic structures on both the planning and the CBCT scans
and thus establish the accuracy that can be achieved with optimally executed on-
line corrections based on XVI registration. To verify the quality of the registration
for the vocal cords, the coordinates of three representative points encompassing
the soft tissue region of interest were checked in each CBCT vs planning CT after
registration. The anatomical reference points used were; the front node of the
thyroid cartilage, and the centers of the left and the right arytenoids (see the red
crosses in figure 3.1 and figure 3.2). The residual errors in the position of the
center of mass (COM) of these points were calculated.
The residual inter-fractional positional variations were calculated for each
26
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patient and for the entire population and are summarized here in the standard
representation of systematic and random errors [123]. Residual average systematic
errors (µ) in the in the cranial-caudal (CC), anterior-posterior (AP) and medial-
lateral (ML) directions were calculated by determining the mean offset of COM of
the vocal cords for each patient from all the fractions and calculating the average
over all patients. The standard deviation (SD) of patient systematic errors around
this mean is Σ. Population residual random errors (σ) were calculated as the
average root-mean-square of individual random variations [123, 130].
In common practice, treatment couch shifts are applied to correct only the
translational positioning errors (no rotations). The convert-to-corrections option
in XVI calculates such translational table movements, which is ideally corrected
at the correction reference point (center of alignment clipbox). We applied
this translation-only correction also to the CBCT scans and measured the same
residual errors for the anatomical landmarks as described above. Hence, the
importance of the rotation corrections in SVCI can be established.
3.2.4 Intra-observer and inter-observer variations
We assessed intra-observer inaccuracies (SD =σObs) introduced by the manual
measurement of the anatomical landmarks coordinates by repeating the measure-
ments five times independently in five patients (2 fractions for each patient) (50
measurements). Per fraction, the SD of the landmark 5 matches was obtained,
and the average of the thus obtained 10 SDs yielded the estimated intra-observer
measurement inaccuracy σObs. In addition, the inter-observer variations in placing
the clipbox around the VOI and consequently the reproducibility of the XVI-based
corrections were tested for 5 patients (2 observers, 179 fractions) (SD = σClipbox).
Table 3.1: Positioning errors calculated from XVI matching results of the VOI for all
the patients for all the fractions before applying the corrections.
Translations (mm) Rotations (◦)
µTrans ΣTrans σTrans µRot ΣRot σRot
ML -1.3 1.6 1.3 0.7 1.5 1.4
CC -2.4 3.3 2.6 0.8 1.2 1.7
AP 0.2 2.2 1.5 -0.4 1.5 1.1
3.2.5 Margins
Finally, to put the errors we found in this study into use, an estimation of the
CTV-PTV margin is made using a standard margin recipe:
MPTV = 2.5Σ + 1.64
√
σ2organmotion + σ2set−up + σ2p − 1.64σp
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where σorganmotion and σset−up are the SDs of organ motion and set-up random
errors, respectively, and σp is the SD describing the penumbra width (∼ 0.3cm in
water; 6 MV photon beams) [130, 118].
3.3 Results
3.3.1 Analysis of the CBCT-based on-line corrections
A summary of pre-correction positioning errors (translation and rotation) based
on clipbox registration is presented in Table 3.1 (µTrans, ΣTrans, σTrans, µRot,
ΣRot, σRot). The largest errors were detected in the CC direction (µTrans =-
2.4mm, ΣTrans=3.3mm, σTrans =2.6mm, µRot = 0.8◦, ΣRot = 1.2◦, σRot = 1.7◦).
In Table 3.2 we report the residual errors (µ,Σ, σ) calculated at the center of mass
of the anatomically representative points if the thus obtained corrections would
be executed, including rotations corrections. The largest errors observed were
also in the CC direction (µ = -0.2 mm, Σ = 0.5 mm, σ= 0.7 mm). To give a
better insight, a scatter plot of XVI detected positioning errors (pre-correction)
and the residual errors at the center of mass of the vocal cords (post-correction)
is presented in figure 3.3. We have chosen to plot the positioning errors in the
AP direction vs CC direction in 2D because the largest errors were continuously
measured in the CC direction.
Apart from the accuracy obtained at the COM of the anatomical landmarks,
the daily residual set-up errors at the front node of the thyroid cartilage and the
centers of the left and right arytenoids are also relevant. In Table 3.2 and Table
3.3 they are given separately for all 10 patients in all the fractions. The data
are shown here to give a general impression of how good is this clipbox-based
automatic matching procedure for all the relevant structures.
Using the XVI function "convert to table shift", applies only translation
positioning correction as explained in the material and methods section of this
article. Population residual errors in set-up after applying translation corrections
only (no rotation) are presented in Table 3.3. The accuracy is almost identical
to the accuracy obtained when including rotation corrections. Once again, the
largest residual errors were noticed in the CC direction (µ = 0.1 mm, Σ = 0.3
mm, σ = 0.8 mm).
3.3.2 Intra-observer and Inter-observer effects
The intra-observer inaccuracies (σObs) introduced by the manual inspection of the
coordinates at the COM were 0.2 mm, 0.6 mm, and 0.4 mm in the ML, CC, and
AP directions, respectively, comparable to the observed random residue errors
(Table 3.2 and Table 3.3).
The impact of the inter-observer variability in selecting a clipbox around the
VOI, on the CBCT registration, yielded a population average SD σClipbox of 0.3
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Figure 3.3: Measured set-up errors of 10 patients in 264 fractions in the CC and AP
directions before (grey squares) and after (black dots) applying corrections (translations
and rotations). The grey and white ellipses indicate the mean systematic errors within
µ± 2Σ intervals before and after applying the on-line corrections, respectively.
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Table 3.2: Residual errors at the three representative structures spanning the vocal cords
and at the COM of these structures after applying the XVI-based corrections (translations
and rotations) calculated for all the patients for all the fractions, σCorrected =√
σ2 − σ2Obs
.
mm µ Σ σ σObs σCorrected
ML
Thyroid 0.0 0.1 0.5 0.1 0.5
R-arytenoid 0.0 0.1 0.6 0.3 0.5
L-arytenoid 0.1 0.1 0.5 0.3 0.4
COM 0.0 0.1 0.3 0.2 0.2
CC
Thyroid -0.2 0.5 0.8 0.4 0.7
R-arytenoid -0.2 0.7 1.1 1.2 0.0
L-arytenoid -0.1 0.6 1.1 1.0 0.5
COM -0.2 0.5 0.7 0.6 0.4
AP
Thyroid 0.1 0.3 0.6 0.3 0.5
R-arytenoid 0.0 0.3 0.7 0.7 0.0
L-arytenoid 0.0 0.5 1.0 0.5 0.9
COM 0.0 0.2 0.5 0.4 0.3
30
On-line image-guidance for vocal cord tumor targeting
mm, 0.5 mm, and 0.3 mm along the ML, CC, and AP directions, respectively.
The corresponding values for rotational errors were 0.7◦, 0.8◦, and 0.7◦ about the
ML, CC, and AP axes, respectively.
Table 3.3: Residual errors at the three representative structures spanning the vocal
cords and at the COM of these structures after applying the table shift XVI corrections
(translational only corrections) σCorrected =
√
σ2 − σ2Obs.
mm µ Σ σ σObs σCorrected
ML
Thyroid 0.0 0.2 0.3 0.1 0.3
R-arytenoid 0.0 0.1 0.4 0.3 0.3
L-arytenoid 0.1 0.1 0.4 0.3 0.3
COM 0.0 0.0 0.1 0.2 0.0
CC
Thyroid 0.2 0.6 1.2 0.4 1.1
R-arytenoid 0.2 0.7 1.0 1.2 0.0
L-arytenoid 0.1 0.4 1.0 1.0 0.0
COM 0.1 0.3 0.8 0.6 0.5
AP
Thyroid 0.1 0.2 0.6 0.3 0.5
R-arytenoid 0.1 0.3 0.8 0.7 0.4
L-arytenoid 0.2 0.5 0.9 0.5 0.7
COM 0.1 0.2 0.5 0.4 0.3
3.3.3 Margins
For inter-fraction motion, we used the values given in this paper (Table 3.2),
uncorrected for observer errors in order to give a conservative estimate of necessary
margins. For intra-fraction motion, values were taken from our previously
published work [93]. Respiratory-induced random positional deviations of one
vocal cord (population based) were calculated assuming symmetrical movements
of the two cords towards the midline ( σResp = σResptot√2 ) where σResp and σResptot
are the random error component of one cord movement and from both cords,
respectively. This produces random errors of 0.7 mm, 0.8 mm, 0.5 mm in the ML,
CC and AP, respectively. Using a single phase from the 4D-CT set that represents
the tumor in its time-weighted mean position to plan the treatment, systematic
error could be reduced to nearly zero and respiratory motion contribution to the
margins will stem from purely random errors. Inserting these values of respiratory
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induced and set-up errors into the margin recipe yields margins of 0.4 mm, 1.5
mm, and 0.6 mm in the ML, CC, and AP directions, respectively.
3.4 Discussion
In the present study, we look at inter-fraction motion of the volume of interest
using daily CBCT scans. As set-up errors commonly observed in mask-fixed
patients [48, 63, 71] are too large for SVCI, we also determined the positioning
accuracy that can be obtained with on-line CBCT corrections. The results
demonstrate the feasibility of positioning the cords using the described on-line
procedure fast and accurately. The residual errors at the COM of the anatomical
structures spanning the vocal cords are sub-mm in all three orthogonal directions.
The largest positioning errors both pre-correction and post-correction were
observed in the cranial-caudal direction, see Table 3.1, Table 3.2 and Table 3.3.
One possible reason is that the reference CT used to register the daily CBCT had
2.5 mm slice thickness. This might cause registration errors in that direction when
dealing with small structures of dimensions that are comparable to the CT slice
thickness. For clinical SVCI application, the latter slice thickness will be reduced
to 1 mm, as allowed by current multi-slice CT scanners [93]. Furthermore, a reason
for the relatively large pre-correction cranial-caudal errors (see figure 3.3) may be
rooted in the registration of the breathing averaged CBCT scans to a multi-slice
spiral CT scan that does not precisely reflect the breathing averaged position.
This effect is not particularly relevant for this study as the final systematic errors
are reduced to <1 mm by the on-line corrections. Nevertheless, in the clinical
SVCI procedure this effect can be avoided by using the 4D-CT scans of patients
to construct the breathing averaged positions.
The intra-observer measurement inaccuracies in determining residue errors
were comparable to the actual values of the residue errors (see σObs and
σCorrected =
√
σ2 − σ2Obs in Table 3.2 and Table 3.3). In Table 3.2 and Table 3.3
more insight is given by reporting the residual errors at the individual anatomical
points. These results demonstrate the small residual errors at these points
especially after the correction for the intra-observer random variation σCorrected.
This result indicates that the automatic matching method delivers appropriate
corrections for the true volume of interest (vocal cords) and that measured residual
errors might originate largely from observer introduced variability (in particular,
the exact position of the arytenoids is not trivial to determine). Furthermore,
it implies that the already small residue errors reported in this study will in
actuality be even smaller (Table 3.1 and Table 3.2). In addition, it was found
that with clear guidelines of which structures to include in the clipbox, the effects
of inter-observer variation in choosing a clipbox around the VOI were negligible.
The automatic XVI registration of CBCT and planning CT scans was easy, fast
and directly successful for nearly all cases. Moreover, the inter-observer variation
in the placement of the clipbox around the VOI and its effect on the XVI-based
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positional corrections was small (≤ 0.5mm). Nevertheless, for one of the patients
in this study the grey value match of the last 15 fractions was not satisfactory.
This could be explained from unusual large volumetric differences due to patient
weight change between the planning CT and the CBCT scan as visually evident
from the CBCT scans. In this case, we employed the automatic bone matching
of the XVI system. Comparing the residues obtained from these bone-matched
fractions with the first 15 fractions (grey-value-based) no significant difference was
detected in the SD of residue positioning errors. This example illustrates that it
is crucial to monitor the quality of all automatic registration results.
The small translational and rotational set-up corrections detected in this
study (Table 3.2) as well as previously reported values for head-and-neck patients
immobilized with thermoplastic masks [48, 43] indicate that the initial positioning
reproducibility is sufficient to present a good starting point for on-line CBCT
registration and corrections. As this study indicates, no special immobilization
techniques seem to be required for SVCI as long as on-line 3D corrections can be
performed and the fitting of the mask is monitored.
We aim at developing an external beam treatment technique for highly focused
irradiation of only the involved vocal cord in early glottic carcinoma for which
precision is a prerequisite. Such a single vocal cord irradiation (SVCI) requires
advanced techniques to achieve the highest level of conformality possible to
fully cover the CTV and simultaneously spare the surrounding structures. The
required conformality is always perturbed by variations in organ position (both
inter-fraction and intra-fraction) and in beam geometry and fluence delivery.
Furthermore, for the very small treatment fields required and the proximity of
the CTV to both air and cartilages high accuracy of the dose calculation and
robustness of the dose distribution against geometrical variations is not trivial.
In a previous paper, we have assessed the intra-fraction motion of the
vocal cords due to breathing using 4D-CT [93]. The intra-fractional breathing
movements of the vocal cords were small compared to the gap size between them.
Hence, the use of gating seemed not required to counter intra-fraction motion, but
4D-CT scans were useful to determine average organ positions and variations.
Having established the intra-fraction and inter-fraction geometrical delivery
inaccuracies, and a method to reduce the latter to sub-mm range, we are now
in position to develop an appropriate irradiation technique for SVCI. The full
procedure will involve various levels of sophistication.
In a simple procedure we are presently developing for plan design, a 4D-
CT scan is obtained from which an appropriate breathing averaged 3D scan is
selected. Next, the population statistics we have obtained for the cord motion in
regular breathing and CBCT on-line corrections may be applied to calculate CTV-
PTV margins. Using the thus obtained PTV, a treatment plan can be created
using small fields and (non-co-planar) beam angle optimization. We consider
it a minimum requirement that thus calculated dose distributions are verified
using Monte Carlo simulations. If necessary, the fluencies must be adapted until
appropriate target dose is achieved. Finally, the thus obtained optimized plan
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can be delivered using daily CBCT guidance as described in this paper.
For final clinical application, the approximate margin estimation provided by
a margin recipe may be too limited. For instance, the recipe derived by van Herk
et al. holds for ideal (isotropic) conformal dose distributions with a constant
penumbra width along the entire PTV surface while the CTV can only translate
and has dimensions » SD of the geometrical variations. For the irradiation of a
small, longitudinal structure, partly surrounded by air as well as nearby cartilages,
these assumptions obviously break down [6, 18]. Even if these assumptions hold,
the margin recipe prescribes a margin that guarantees a minimum dose to the
CTV of 95% of the prescribed dose in 90% of the patients. That may not be
sufficient coverage to conserve the excellent local control now observed using
generous fields. Although the recipe of Stroom et al. is based on clinical treatment
plans, it suffers from similar drawbacks as the van Herk recipe.
For future work we therefore extend the method we recently developed for
handling organ motion and deformation [21, 129] to design SVCI plans without
reliance on a margin recipe. This method allows tracking voxels under all known
geometrical uncertainties and performs dose accumulation in simulations of actual
treatments. The dose in the voxels is accumulated over all known degrees of
freedom to obtain effective delivered dose distributions [21]. Thus, the initial
margin design can be evaluated, and margins tuned to the specific patient anatomy
and motion patterns.
Another aspect that should be considered is the precision of our system in
executing the required positioning corrections. In a previous study, Mutanga et
al. reported that the precision of the Theraview Couch Set-up Assistant (TCSA)
system used in our institute is 0.3 mm in all three directions [82]. Moreover,
other intra-fraction errors, movements inside the mask especially for prolonged
treatment [71, 8], are also a subject for investigation. In a new protocol of
imaging laryngeal cancer patients in our institute, post-treatment CBCT scans
are acquired to investigate and quantify the residual intra-fraction errors. To
help reducing the latter errors more attention is paid to make best-fitting masks
for positioning the patients and patients’ weight changes during the course of
treatment will be monitored.
3.5 Conclusions
On-line registration and correction using available CBCT acquisition and reg-
istration software can yield sub-mm systematic and random displacements for
the vocal cords when combined with standard mask fixation. Thus, the high
positioning accuracy required for single vocal cord irradiation may be achieved
in a clinically feasible procedure. Estimated safety margins required to account
for inter-fraction as well as intra-fractional set-up variations are small enough
(0.4− 1.5mm) to spare the healthy vocal cord.
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Abstract
Purpose: We have been developing an image-guided single vocal cord irradiation
technique to treat patients with stage T1a glottic carcinoma. In the present study,
we compared the dose coverage to the affected vocal cord and the dose delivered to
the organs at risk using conventional, intensity-modulated radiotherapy (IMRT)
coplanar, and IMRT non-coplanar techniques.
Methods and Materials: For 10 patients, conventional treatment plans using
two laterally opposed wedged 6-MV photon beams were calculated in XiO
(Elekta-CMS treatment planning system). An in-house IMRT/beam angle
optimization algorithm was used to obtain coplanar and non-coplanar optimized
beam angles. Using these angles, the IMRT plans were generated in Monaco
(IMRT treatment planning system, Elekta-CMS) with the implemented Monte
Carlo dose calculation algorithm. The organs at risk included the contra-lateral
vocal cord, arytenoids, swallowing muscles, carotid arteries, and spinal cord. The
prescription dose was 66 Gy in 33 fractions.
Results: For the conventional plans and coplanar and non-coplanar IMRT plans,
the population-averaged mean dose ± standard deviation to the planning target
volume was 67 ±1 Gy. The contra-lateral vocal cord dose was reduced from
66 ± 1 Gy in the conventional plans to 39 ± 8 Gy and 36 ± 6 Gy in the coplanar
and non-coplanar IMRT plans, respectively. IMRT consistently reduced the doses
to the other organs at risk.
Conclusions: Single vocal cord irradiation with IMRT resulted in good target
coverage and provided significant sparing of the critical structures. This has the
potential to improve the quality-of-life outcomes after RT and maintain the same
local control rates.
IMRT for single vocal cord RT
4.1 Introduction
The ultimate goal of radiotherapy (RT) is the total eradication of tumors while
minimizing the toxicity to the surrounding healthy structures. In early glottic
carcinoma treated with RT, large box fields, using wedged parallel opposed photon
beams, have been used conventionally. The tumor-free contralateral vocal cord,
arytenoids, thyroid cartilage, and all muscles responsible for opening and closing
the vocal cords receive the full dose of 66 Gy. In this conventional method,
the swallowing muscles, carotid arteries, thyroid gland, and thyroid and cricoid
cartilages among other structures, are partly in field. Exposure of these structures
to high radiation doses (fully or partially) could lead to an increased probability of
complications that negatively influence the quality of life of these patients. Typical
complications have involved voice/speech impairment, diet problems (swallowing,
trismus), arytenoid edema, an increased risk of strokes, and reduced treatment
options for previously irradiated patients [26, 100, 104].
Very good local control rates have been obtained with simple parallel opposed
beams used conventionally. However, efforts should be made to reduce the dose
received by the tumor-free laryngeal structures to reduce the radiation-related
complications in this group of patients. Reducing the dose received by the organs
at risk (OARs) might also help in increasing the treatment options for patients
with second primary tumors in the vicinity of the treated tumor. In patients with
successfully treated Stage T1a glottic cancer, the incidence of the development
of a second primary tumor (commonly in the upper aerodigestive track) at 5,
10, and 15 years was reported to be 23%, 44%, and 48.7%, respectively [83].
Given the large radiation treatment fields presently used for these patients, those
second primary tumors have usually been treated surgically with generous surgical
margins that significantly deteriorate the patients’ quality of life after treatment
[114].
At the Erasmus Medical Center, we have been developing a new focused
irradiation technique for early glottic cancer. The introduction of a new technique
brings with it the responsibility of investigating, testing, and verifying all aspects
of the RT process. The geometric uncertainties must be reduced and the residual
uncertainties accounted for by ensuring adequate safety margins for treatment
planning. Accurate dose calculation and treatment delivery are also crucial.
In a previous study, we investigated and quantified the intrafraction respi-
ratory motion of the vocal cords using four-dimensional computed tomography
(CT) scans. It was found that the movement of the vocal cords with breathing
is minimal [93]. In another study, it was shown that it is possible to reduce the
interfraction setup errors to submillimeter values using cone beam CT scans in
an on-line correction protocol [92].
In the present study, we compared the tumor dose coverage and dose delivered
to the OARs using conventional parallel opposed fields with dose delivery
using computer-optimized coplanar and non-coplanar beam setups and intensity-
modulated beam profiles. The dose calculations were performed using a Monte
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Carlo (MC)-based treatment planning system (TPS).
4.2 Methods and Materials
4.2.1 Patients, planning CT scans, and delineations
Ten patients who had been conventionally treated for early-stage glottic carcinoma
(Stage T1aN0M0) were included in the present study. All patients had undergone
four-dimensional CT scanning (Somatom Sensation Open, Siemens Medical
Solutions, New York, NY) before treatment, reconstructed in eight breathing
phases. The CT resolution was 1×1×1mm3. For each patient, the reconstruction
representing the local anatomy in its average respiratory position was used
for planning. The OARs contoured were the contralateral (CL) vocal cord,
arytenoids, swallowing muscle at the level of the vocal cords (inferior constrictor
muscles [ICM], ipsilateral and CL strap muscles), carotid arteries, thyroid and
cricoid cartilages, and spinal cord. The craniocaudal extensions of the contours
for these OARs were the C2 and C6 vertebrae.
In Figure 4.1, an example of a Stage T1 tumor confined to one vocal cord
is shown, as well as a schematic drawing of the delineation method used. The
clinical target volume (CTV) was defined as the whole affected vocal cord as a
conservative measure.
CTV
Thyroid 
cartilage
Air 
 
gap
PTV
Arytenoid
Figure 4.1: (Left) Endoscopic photograph of tumor on one vocal cord and
(Right) schematic drawing showing delineations of clinical target volume (CTV) and
corresponding planning target volume (PTV)
38
IMRT for single vocal cord RT
4.2.2 Margins
In line with the International Commission on Radiation Units and Measurements
recommendations, a planning target volume (PTV) was constructed around the
CTV. A standard margin formula was used:
M = 2.5Σtot + 1.64σtot − 1.64σp,
where Σtot =
√
Σ2intrafraction + Σ2interfraction, σp is the standard deviation describ-
ing the penumbra width and
σtot =
√
σ2intrafraction + σ2interfraction + σp [130]. The mean penumbra width
was 0.4cm (the smallest distance between the 95% and 50% isodose lines in the
plans). Using the CT scan with the tumor in its average position for planning,
the systematic respiratory error could be reduced to nearly 0, and the respiratory
motion contribution to the margins stemmed from purely random errors. We
included the uncertainties from the intrafraction respiration [93], and the residual
interfraction setup errors (assuming on-line setup corrections to be performed),
as measured and explained in our previously published study [92]. For prolonged
treatment sessions (≥ 15min), the effects of the intrafraction setup errors might
not be negligible and should be accounted for [45]. Nevertheless, it has generally
been agreed that the magnitude of the intrafraction setup errors will be less than
that of the interfractional setup errors [30]. In the present study, the intrafraction
setup uncertainties were estimated to be equal to the interfraction uncertainties
as a reasonable (upper limit) estimate. Using this procedure, margins of 0.5, 1.7,
and 0.8mm in the mediolateral, craniocaudal, and anteroposterior directions were
calculated. Given the 1mm3 resolution of the CT scan, practical margins of 2mm
in three-dimensions were used for the present study.
4.2.3 Treatment plans
Conventional plans.
Conventional clinical treatment plans using two laterally opposed wedged photon
beams were performed using the XiO TPS (version 4.33, Elekta-CMS). The
superior border of the treatment fields was the hyoid bone, and the inferior
border was the lower edge of the cricoid cartilage. The fields were 1cm "falling
off" anteriorly, and the posterior border was at the anterior vertebrae [52]. The
prescribed dose to the "box" outlined by the treatment fields was 66 Gy at the
100% isodose, given in 33 fractions at six fractions weekly. The dose was calculated
using the fast superposition algorithm in XiO.
Design of IMRT plans and optimization procedure.
An in-house-developed IMRT/beam angle optimization algorithm (iCycle) was
used to obtain the beam angles for each patient using a set of standardized
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Table 4.1: Wish list used in iCycle showing constraints and objectives used in
optimization
Constraints
Volume Type Limit (Gy)
PTV Minimum 63
PTV Maximum 68
Spinal Cord Maximum 45
Unspecified Tissue Maximum 70
Objectives
Priority Volume Type Goal (Gy)
1 CL vocal cord Mean 30
2 CL arytenoid Mean 50
3 IL arytenoid Mean 66
4 ICM Mean 26
5 Unspecified Tissue Minimize EUD 10
Abbreviations: PTV = planning target volume; CL = contralateral;
ICM = inferior constrictor muscles; EUD = equivalent uniform dose
constraints and objectives [110]. iCycle uses a list with constraints and prioritized
objectives (a "wish list" for beam angle optimization (Table 4.1). The constraints
were hard and must be fulfilled at all times. The objectives were processed in
priority. The highest prioritzed objective was to minimize the mean dose to the
CL vocal cord to an acceptable level of 30 Gy (i.e., its "goal"). The second priority
was to minimize the mean dose to the CL arytenoid to an acceptable level of 50
Gy, and so forth for the ipsilateral arytenoid, ICM, and unspecified tissue. The
list was processed in 2 phases. In the first phase, it sought to attain the goals as
well as possible. In the second phase, the objectives for which the goal could be
attained were minimized to their fullest. From this wish list, iCycle sequentially
adds beams to the plan to a maximum of five beams.
The optimized iCycle beam angles were then imported into the Monaco
TPS, version 1.00 (Elekta-CMS) to generate plans with a MC dose calculation
algorithm. In the Monaco TPS, the plans were configured using biological and
physical constraints [42, 126, 111]. For the PTV, a Poisson cell kill model was
used combined with a quadratic overdose constraint to avoid hot spots inside the
PTV. For the CL vocal cord and the spinal cord, serial complication models were
used to limit the maximal dose to both structures. Quadratic overdose constraints
were also applied to limit the dose to unspecified tissue. The beams were then
segmented, and their weights were optimized in the second optimization phase
using a photon MC dose engine (XVMC) based on the voxel MC code [32].
All calculations for the IMRT plans were done for 6-MV photons with a
calculation grid spacing of 1.5 mm. The accelerator used was an Elekta Synergy
with 40 multileaf collimator leaf pairs, and the leaf width at the isocenter was
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4 mm (Elekta Beam Modulator, Elekta Oncology Systems, Crawley, UK). The
minimal segment size allowed was 0.5 cm2. The isocenter was set to the center
of the CTV. The dose prescribed to the PTV was 66 Gy, given in 33 fractions
(six fractions weekly) using the clinical fractionation scheme. The PTV partially
consist of air. No dose was deposited in that part of the PTV. The Monaco TPS
feature "auto flash" creates a flash margin of the voxels that extends beyond the
surface of the patient (into the air cavity in this case) so that the prescribed dose
can be achieved. A "flash margin" of 2 mm around the PTV was used in planning.
Thus, dose coverage was also provided for the moving vocal cord (CTV) in and
out of the air gap during breathing and in the case of setup errors.
Plan evaluation
The population-averaged dose-volume histograms (DVH), mean doses, and, in
some cases, maximal doses were used to evaluate and compare the different
plans. For the CTV and selected OARs, the generalized equivalent uniform doses
[EUD(a)] [85] were calculated and compared for the different planning techniques.
The values of the tissue-specific parameter a used for the CTV were a = −5 and
a = −20, because no clear data are available about the values that should be used
for these tumors. For the OAR, a = 2.2 was used, as recently recommended by
Rancati et al. [100]. Statistical analysis was performed in MatLab using pairwise
Wilcoxon signed-rank tests at a significance level of p ≤ .05. Separate analyses
were performed to compare conventional planning with the IMRT coplanar plans
and to compare the IMRT coplanar and IMRT non-coplanar plans; no multiple
comparison was performed. The fractional volumes of the PTV and CTV that
received ≥ 95% of the prescription dose were also reported. For the OARs, the
population-averaged mean doses (± standard deviation) and the maximal doses
to the spinal cord and carotid arteries were reported. It has been recommended
to keep the dose in the larynx less than ∼ 66 Gy for vocal function preservation
[100]. Therefore, the volume of the CL vocal cord that received ≥ 95% of the
prescribed dose or more was also reported. It has also been recommended to
limit the mean dose to the non-involved larynx to 40 Gy, because the published
data have indicated threshold doses of 40−45 Gy for the onset of other functional
complaints [100, 107]. Therefore, we have also reported the fraction of the volume
of the CL vocal cord that received a dose of 40 Gy. Furthermore, the volume of
the carotid arteries that received ≥ 35 Gy are also reported, because reports have
been published of complications with carotid doses 35 Gy [104].
4.3 Results
4.3.1 iCycle optimized coplanar and non-coplanar beam angles
For each patient, a coplanar and non-coplanar set of optimized beam angles was
obtained. The distribution of the iCycle beam angles for the 10 coplanar plans is
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shown in figure 4.2 for tumors on the left vocal cord. Generally, anterior beams
have been favored with a wide range of angles. The class solution beam angles
used were indicated with asterisks. Non-coplanar iCycle optimized beam angles
are presented in Table 4.2.
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Figure 4.2: iCycle coplanar beam distributions for left vocal cord tumor. Optimized
angles for right side tumors have been mirrored for this representation. Thicker lines
indicate directions chosen more than once. Class solution angles shown in red with
asterisk.
4.3.2 Conventional technique vs. coplanar and non-coplanar
IMRT
The beam setups obtained with iCycle were used to plan the treatments in the
Monaco TPS. Because of the observed similarity in the selected beam angles for
the patients (fig 4.2), we selected one set of five beam angles and tested whether
this could be used as a class solution for all patients. This could serve for the
simplicity and standardization of treatment delivery in practice. For patients
with tumor on the left vocal cord, beam angles of 30◦, 85◦, 320◦, 335◦, 350◦ were
used. For those with right vocal cord tumors, mirrored angles were used. Figure
4.3 shows the comparisons between doses received by the different structures,
using the individualized beam arrangement and the class solution. No significant
differences in the delivered doses to the different structures were observed (all
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Table 4.2: iCycle individualized non-coplanar beam arrangements
Beam 1 2 3 4 5
P1 (Left) 330, 0 15, 270 54, 341 319, 352 337, 333
P2 (Left) 345, 0 344, 289 334, 37 37, 343 329, 10
P3 (Left) 33, 22 342, 56 339, 346 27, 22 330, 0
P4 (Right) 23, 333 18, 56 36, 351 323, 17 54, 341
P5 (Right) 16, 342 344, 289 37, 17 313, 346 34, 333
P6 (Right) 15, 0 344, 71 30, 31 296, 17 49, 340
P7 (Right) 23, 333 0, 0 36, 9 301, 18 27, 22
P8 (Right) 16, 342 15, 90 26, 12 306, 19 22, 315
P9 (Right) 10, 0 44, 338 15, 270 284, 5 18, 34
P10 (Right) 25, 0 344, 71 36, 9 284, 5 26, 323
Abbreviation: P = patient.
Data presented as (gantry, couch) angles; gantry and couch rotate clockwise.
p > 0.05). This could have been a result of the degeneracy of the solution space
[110, 73]. Although not significant, the class solution seemed to result in somewhat
better sparing for some OARs. This could have resulted from the different dose
calculation algorithms used; the pencil beam algorithm without adequate MLC
segmentation in iCycle in which optimized IMRT beam angles were generated, and
in Monaco, with a MC-based dose engine and full MLC segmentation. For the
sake of simplicity, all the following results for coplanar IMRT plans were produced
with the proposed class solution. For non-coplanar plans, the individualized beam
angles, as obtained using iCycle (Table 4.2), were planned in Monaco, because it
was more complicated to cluster the beam and couch angles.
Figure 4.4 shows the dosimetric comparisons among the conventional, coplanar
IMRT, and non-coplanar IMRT plans. Comparing the conventional plans with the
IMRT coplanar plans, similar mean doses to the CTV (p = 0.2) and PTV (p = 0.1)
were obtained with both techniques. Furthermore, almost all OARs (CL vocal
cord, CL arytenoid, carotid arteries, ICM, thyroid, cricoid, and strap muscles)
were significantly spared with the IMRT plans compared with the conventional
plans (all p = 0.002, except for the ipsilateral carotid arteries p = 0.004). The
PTV extended to partially cover the ipsilateral arytenoids. Accordingly, doses
similar to the conventionally delivered doses were achieved using IMRT (p = 0.4).
Compared with coplanar IMRT, only the CL arytenoid was spared more when
using non-coplanar beams (p = 0.01).
For coplanar IMRT plans, the smallest field size was 2 × 2.5cm2, and each
plan had on average four segments/beam. The average number of monitor units
required to deliver the dose was 441 ± 81. Similarly, for non-coplanar plans, an
average of four segments/beam was used, and the smallest field size was 2×2cm2.
The average number of monitor units was 509± 145.
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Figure 4.3: Mean/maximal doses to different structures from coplanar individualized
(iCycle) beam angles and for class solution. For carotid arteries and spinal cord, maximal
doses shown. Error bars represent ± standard deviation. p Values shown for Wilcoxon
signed-ranked tests for individualized beam setups vs. class solution doses. CL =
contralateral; v = vocal; IL = ipsilateral; m = muscle.
In figure 4.5, a typical example of the dose distributions of a conventional
plan and IMRT coplanar and non-coplanar setups are shown for 1 patient. The
superiority of single vocal cord irradiation (SVCI) is clearly visible. This was
also evident in figure 4.6, in which the population mean DVHs for the different
planning techniques are presented.
For the CTV, CL vocal cord, and the arytenoids, the EUD mean values (±
standard deviation) obtained from the different planning techniques are presented
in Table 4.3. The data show substantial and statistically significant sparing of
the CL vocal cord and CL arytenoid for SCVI with IMRT. The EUD(−5) and
EUD(−20) for the CTV were slightly (but statistically significantly) elevated in
the IMRT plans compared with the conventional plans, showing that the large
reduction in OAR doses with IMRT could be obtained while also giving a slightly
greater dose to the CTV. Several dose-volume parameters for the CTVs and the
contralateral vocal cord are listed in Table 4.4. The percentage of the CTV
receiving ≥ 95% of the dose was, for all plans, ≥ 99%. Only 86% and 88% of
the PTV received ≥ 95% of the prescribed dose in the coplanar and non-coplanar
plans (see PTV DVH in figure 4.6). This is due to the fact that the PTV extends
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Figure 4.4: Delivered doses for planning target volume (PTV) and organs at risk
(OARs) from conventional and intensity-modulated radiotherapy (IMRT) coplanar and
non-coplanar plans. For carotid arteries and spinal cord, population average maximal
doses shown. For other structures, mean doses depicted. Error bars represent ± standard
deviation. p Values shown for Wilcoxon signed-ranked tests for doses delivered using
IMRT coplanar vs. non-coplanar beam setups. CL = contralateral; v = vocal; IL =
ipsilateral; m = muscle. *Statistically significant.
into the air gap of the larynx. Applying a flash margin (see the "Methods and
Materials" section), similar fluences were deposited to the PTV (i.e., opening the
leaves to conform to a virtual target). The whole CL vocal cord received ≥ 95%
of the prescribed dose in the current conventional plans; however, in the IMRT
plans, only a small fractional volume received such high doses.
On average, the percentage of the volume of the carotid arteries that received
a dose of ≥ 35 Gy in the clinical plans was 86% for the ipsilateral carotid and
92% for the CL carotid artery. However, a major reduction in the dose received
to both carotid arteries was achieved using SVC IMRT because no parts of the
arteries received any dose > 35 Gy (see also the maximal dose to the carotid
arteries in figure 4.4 and the DVHs in figure 4.6.
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Figure 4.5: Transverse views at isocenter level for 1 patient showing dose distributions
for (A) conventional, intensity-modulated radiotherapy (B) coplanar (class solution),
and (C) non-coplanar plans.
Table 4.3: Generalized equivalent uniform dose parameters for different plans
Variable Conventional plans IMRT coplanar P 1 IMRT non-coplanar P 2
CTV
EUD(-5) 67.6± 1.0 68.6± 0.3 0.03∗ 68.3± 0.8 0.3
EUD(-20) 67.6± 1.0 68.4± 0.3 0.05∗ 68.0± 0.9 0.3
CL vocal cord
EUD(2.2) 67.3± 1.0 41.2± 5.7 0.002∗ 40.2± 5.7 0.3
Ipsilateral arytenoid
EUD(2.2) 66.2± 1.4 63.9± 3.9 0.3 65.1± 1.7 0.3
CL arytenoid
EUD(2.2) 66.2± 1.7 22.1± 8.6 0.002∗ 12.6± 4.1 0.01∗
Abbreviations: IMRT=intensity-modulated radiotherapy; CTV=clinical target
volume; EUD=equivalent uniform dose; CL=contralateral.
1 Conventional vs. IMRT coplanar plans.
2 Coplanar vs. non-coplanar plans.
∗Statistically significant.
4.4 Discussion
We have conducted a planning study for one-sided early glottic cancer to compare
the conventional RT technique (using wedged parallel opposed fields) with highly
focused IMRT. Although IMRT might not be necessary to control early-stage
squamous cell carcinoma of the larynx, the added value of normal tissue sparing
has made it clinically relevant. We found the dose received by healthy structures
in the vicinity of targets can be significantly reduced with the proposed technique
without compromising the target coverage ([Table 4.3] and [Table 4.4] and figure
4.4).
In the present report, we have proposed a class solution for coplanar beam
angles to be used as a template for SVCI in the treatment of early-stage glottic
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Figure 4.6: Population mean dose-volume histograms from different planning
techniques shown for selected structures. Shaded areas indicate ranges (population
minimal and maximal dose-volume histograms). Asterisk indicates partially contoured
organs at risk. CL=contralateral; IL = ipsilateral; m = muscle; ICM = inferior
constrictor muscle.
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cancer. This class solution was derived from full IMRT/beam angle optimization
for the patients in the present study using an in-house-developed optimizer.
Comparing the dose parameters for the different OARs using the individualized
plans with respect to the proposed class solution, little difference was found,
suggesting that the class solution is a valid template (figure 4.3). Using this class
solution will reduce the complexity and allow quicker plan generation compared
with individualized beam setups. Adding non-coplanar beams resulted in little
improvement in plan quality (figure 4.4). Having non-coplanar beams would
significantly increase the treatment time compared with coplanar treatment.
Moreover, it will introduce positioning difficulties that might not be justified by
the small gain in OAR dose reduction.
As demonstrated in figure 4.4 and Table 4.3, SVCI results in major sparing
of the CL vocal cord, CL arytenoid, ICM, strap muscles, thyroid and cricoid
cartilages, and carotid arteries compared with conventional RT. For the ipsilateral
arytenoid and anterior commissure, we allowed high doses (similar to that with the
conventional plans) to avoid target underdosage. For the IMRT plans, the dose
to the spinal cord increased with respect to the conventional plans but remained
far below the specified limit of 45 Gy.
As mentioned in the "Methods and Materials" section, analysis of the target
coverage using the PTV concept would be inaccurate for SVCI because of the air
present in the volume. The use of the flash margin should guarantee proper target
dose delivery in the case of motion. This is a topic for additional investigation.
Although RT was reported superior to laser surgery in terms of voice
preservation, a number of studies have reported that the voice does not return
to normal after RT [5, 22]. Other studies comparing laser surgery and RT as
treatment options reported comparable local control and voice quality outcomes
from the two treatment modalities [136]. These studies compared RT techniques
using conventional "box" RT fields (with high doses to all structures included)
with localized laser surgery. This provided a strong motive to hypothesize that
more focused RT techniques could provide better results in terms of quality of
life compared with laser surgery. It could also provide better local control among
this group of patients by offering the potential for dose escalation. The increased
sparing of the OARs might also allow the application of hypofractionation schemes
to reduce the overall treatment time and increase patient comfort.
It has generally been agreed that reducing the doses to the laryngeal structures
has the potential to reduce the complications related to RT (e.g., swallowing,
speech, persistent edema) [26, 100, 4]. More recent studies have also highlighted
the increased risk of strokes and direct carotid artery injury that could result
from high-dose irradiation of the carotid arteries (usually 66 Gy) [104, 14]. Both
groups showed a huge reduction of the dose to the carotid arteries when using
IMRT for early glottic carcinoma, which was confirmed by our study. Limiting
the dose to the carotid arteries might also allow re-irradiation when necessary.
Several groups have opposed the use of IMRT for early glottic cancer [74, 31].
Their main concern has been that the use of IMRT will compromise local control
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Table 4.4: Dosimetric parameters for CTV and contralateral vocal cord for different
planning techniques.
Variable Conventional plans IMRT coplanar P 1 IMRT non-coplanar P 2
CTV
V95%
Mean ± SD 100.0± 0.0 99.9± 0.2 1.0 99.6± 0.9 0.5
Range 100− 100 99.4− 100.0 97.4− 100.0
Median 100.0 100.0 100.0
CL vocal cord
V95%
Mean ± SD 100.0± 0.0 8.1± 6.5 0.004∗ 8.5± 6.7 0.6
Range 100.0− 100.0 2.0− 19.4 3.0− 20.2
Median 100.0 5.8 6.3
V40Gy
Mean ± SD 100.0± 0.0 39.9± 14.5 0.002∗ 38.0± 15.3 0.5
Range 100.0− 100.0 19.2− 65.4 22.0− 72.4
Median 100.0 38.5 34.0
Abbreviations: V95%=fractional volume that received ≥ 95% of prescription dose;
SD=standard deviation; V40Gy=volume receiving dose ≥ 40Gy.
1 Conventional vs. IMRT coplanar plans.
2 Coplanar vs. non-coplanar plans.
∗ Statistically significant.
by failing to deliver adequate doses to a small primary cancer that conventional
approaches cannot miss. Another concern has been the limitations of the
calculation algorithms that can result in over- or underdosage at the tissue-
air interface. Special attention should also be paid to the potential enhanced
occurrence of second primaries with the small fields used in SVCI, because
evidence has shown that RT might delay the occurrence of these second tumors
[101].
All these valid points were carefully taken into consideration in the present
study of SVCI. We have proposed that with the introduction of on-line image-
guided RT and the availability of more accurate calculation algorithms in
commercially available TPSs, the reduction of the treated volumes is a reasonable
step to undertake. In contrast to all previous studies, we defined the CTV (the
whole affected vocal cord) contoured on the CT scans with 1 −mm3 resolution.
The intra- and interfractional setup errors have been thoroughly investigated,
quantified, and reduced [93, 92]. Residual geometric errors were used to construct
the CTV-PTV safety margins. The dose was calculated using MC in the Monaco
TPS. The results in the present study indicated a tremendous reduction in the
doses received by the OARs using the SVCI technique.
In preparation for the SVCI -IMRT technique we have introduced, studies
on the dosimetry and dose modeling, especially in the buildup region, must be
carefully conducted. In our clinic, some of the IMRT beams from the presented
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plans were verified using a two-dimensional detector array [111]. Gamma analyses
showed good agreement between the dose distributions calculated using the
Monaco TPS and the measured distributions. Before the clinical introduction
of this treatment, more extensive studies on the accuracy of the dose engine
near tissue inhomogeneities will be conducted. SVCI should be considered an
experimental technique that has yet to be clinically proven. We believe that SVCI
should not be applied outside well-controlled clinical studies to prove its efficacy.
The extremely high-treatment precision required can only be guaranteed with
daily on-line image-guided RT protocols, advanced dose-calculation engines, and
a very extensive quality assurance program conducted by experienced personnel.
4.5 Conclusions
Evidence was found that image-guided SVCI using IMRT can provide significant
sparing of critical structures without compromising CTV coverage, thus offering
the possibility of better voice and swallowing function preservation. A huge
reduction in the maximal dose received by the carotid arteries was also observed.
This has the potential to reduce the risk of stroke and might also allow re-
irradiation (if the need arises because of second primaries in the vicinity),
especially in younger patients. A class solution of beam angles was presented
to ease and standardize treatment planning for a single vocal cord. The proposed
technique also offers the new possibilities of dose escalation and hypofractionation
for this group of patients.
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Abstract
Purpose: To investigate the robustness of single vocal cord IMRT treatment
plans for set-up errors, respiration, and deformation.
Methods and Materials: 4D-CT scans of ten early glottic carcinoma patients,
previously treated with a conventional technique, were used in this simulation
study. For each patient, the pre-treatment 4D-CT was used for IMRT planning,
generating the reference dose distribution. Prescribed PTV-dose was 66 Gy. The
impact of set-up errors was simulated by applying shifts to the planning CT-scans,
followed by dose re-calculation with original beam segments, MUs, etc. Effects of
respiration and deformation were determined with inhale and exhale CT-scans,
and repeat scans acquired after 22 Gy, 44 Gy, and 66 Gy, respectively. All doses
were calculated using Monte Carlo dose simulations.
Results: Considering all investigated geometrical perturbations, reductions in
the CTV V95%, D98%, D2%, and generalized equivalent uniform dose(gEUD) were
limited to 1.2 ± 2.2%, 2.4 ± 2.9%, 0.2 ± 1.8%, and 0.6 ± 1.1 Gy, respectively.
The near minimum dose, D98%, was always higher than 89%, and gEUD always
remained higher than 66 Gy. Planned contra-lateral vocal cord DMean, gEUD,
and V40Gy were 38.2± 6.0 Gy, 43.4± 5.6 Gy, and 42.7± 4.9%. With perturbations
these values changed by −0.1 ± 4.3 Gy, 0.1 ± 4.0 Gy, and −1.0 ± 9.6%,
respectively.
Conclusions: On average, CTV dose reductions due to geometrical perturbations
were very low, and sparing of the contra-lateral vocal cord was maintained. In
a few observations, the near-minimum CTV-dose was around 90%, requiring
attention in deciding on a future clinical protocol.
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5.1 Introduction
Intensity modulated radiation therapy (IMRT) is being increasingly investigated
for the management of early stage squamous cell carcinoma of the larynx [104,
14, 93, 92, 91, 61]. IMRT produces a conformal dose distribution around the
tumor; therefore the surrounding organs at risk (OAR) can be spared more than
what could be achieved with conventional RT techniques. Limiting the dose to
OAR has the potential of reducing RT related toxicity, such as, vocal dysfunction,
dysphagia, trismus, arytenoid edema, carotid arteries injuries, and increased risk
of strokes. IMRT appears not widespread as the standard technique for stage T1
laryngeal cancer, and whenever it is applied, both vocal cords are included in the
treatment volume [104, 14]. The reason for this forbearance in the implementation
of IMRT to this specific tumor site, compared to other head-and-neck tumor sites,
may be the good overall survival currently achieved [61]. Nevertheless, reducing
the dose to normal tissue potentially reduces long term sequelae and improves the
quality of life (QoL), which is important for this category of patients with such a
long term survival. Additionally, limiting the dose to the OARs, potentially yields
another treatment option for patients with re-current tumors; re-irradiation. The
use of IMRT and small target volumes could potentially also allow shorter, more
hypo-fractionated schedules. Safety margins (CTV-PTV) are used to ensure that
the CTV receives adequate coverage during the multi-fraction course of treatment.
IMRT plans usually contain high dose gradients to spare organs at risk adjacent to
target volumes, putting an enhanced stress on selection of appropriate margins.
This is particularly important as it was shown that a small position variation
does not necessarily mean a correspondingly small dose variation and vice versa
in the case of head-and-neck RT because of tissue inhomogeneities and body
contour variations with respect to the beams [6]. IMRT utilizes 3D anatomic
information extracted from CT scans acquired prior to treatment. Nonetheless,
several groups have reported anatomic changes occurring throughout fractionated
external beam radiotherapy [7, 112]. The CTV-PTV margins have to account for
potential anatomical changes during the course of treatment, e.g. caused by tumor
regression or weight loss. In single vocal cord IMRT, applied CTV-PTV margins
also have to compensate for respiratory tumor motion [93, 91]. Recently, it has
been shown that using adaptive radiotherapy (ART) techniques has potential
advantages in preventing many of the above mentioned concerns when treating
head and neck tumors with IMRT [12, 109].
In Rotterdam we have developed a highly focused IMRT technique to only
irradiate the involved vocal cord in early glottic cancer. This was allowed by
recent technological advances in image acquisition with 4D-CT, image-guided
position verification with cone beam CT, and the clinical availability of a TPS with
Monte Carlo dose calculations [93, 92, 91, 61]. With our technique, not only the
distant OARs are spared but also the contra-lateral vocal cord that lies in close
vicinity to the irradiated vocal cord [91]. Single vocal cord irradiation (SVCI)
involves the use of small treatment fields for a tumor surrounded partially by
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air, complicating selection of appropriate CTV-PTV margins. For the treatment
plans generated in [91] (used as reference in this study, see below), an isotropic
CTV-PTV margin of 2mm was used. The current study was conducted to test
the robustness of these IMRT plans against different geometrical uncertainties.
The uncertainties evaluated were; set-up errors, respiratory movements, and inter-
fraction anatomical variations (deformation).
5.2 Methods and Materials
5.2.1 Patients and generation of reference IMRT dose distribu-
tions
Ten patients, previously treated for early glottic carcinoma (T1aN0M0) with a
conventional technique, were retrospectively included in this study. The involved
cases and generation of the reference IMRT dose distributions as used in this
study have been described in detail in [91]. Here a brief summary is provided.
Each patient had a 4D-CT scan acquired before treatment, used to reconstruct
scans for 8 breathing phases [93]. The CT resolution was 1 × 1 × 1mm3. For
each patient, the airgap area at the level of the vocal cords was measured for all
breathing phases. The scan from the phase that measured the middle value for
the airgap was then used as the planning scan. This CT scan represents the tumor
in (or closest to) its average respiratory position. IMRT plans were generated on
these planning scans and the corresponding dose distributions were the reference
distributions as used in this study. The applied CTV-PTV margin was 2 mm
in all directions. A class solution with five beam angles was employed [91]. The
prescribed dose to the CTV was always 66 Gy given in 33 fractions (six weekly
fractions) using 6-MV photon beams. The IMRT treatment plans were generated
with the Monaco TPS, version 1.00 (Elekta-CMS) that uses a MC dose calculation
engine.
5.2.2 Simulation of set-up errors
The effects of set-up errors on CTV dose coverage and on the dose received by the
CL vocal cord were assessed by re-computing the dose distribution for six shifts
of the planning CT-scan (section 5.2.1 above) along the three principal axes (+
and -). Dose re-calculation was performed using the linac parameters (segments,
MUs, etc.) as established for generation of the reference dose distribution (section
5.2.1 above). In a previous work [92] we have presented a daily on-line positioning
procedure for single vocal cord irradiation. We found that the residual positioning
errors after employing this on-line 3D patient setup correction procedure were
below a millimeter. Nevertheless, in this present study shifts of ± 2 mm were
simulated as an upper bound estimate of possible systematic set-up errors in
clinical settings. As patient 6 had no pre-treatment 4D-CT, the described analyses
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were done with the scan acquired after 22 Gy.
5.2.3 Simulation of respiratory motion
For each patient, the extreme inhale and extreme exhale CT scans, reconstructed
from the pre-treatment 4D-CT scan, were used for the simulations. The
manually delineated planning scan (above) was exported to the Atlas-Based
Auto-segmentation (ABAS) software (Elekta/CMS software) to serve as a patient
specific atlas [125] for delineation of the two extreme breathing phases CT scans.
Where needed, the ABAS delineations were edited by an experienced observer
(author 3) [135]. Again, dose calculations for these extreme breathing phases
were based on the original linac parameters. As patient 6 had no pre-treatment
4D-CT, the described analyses were done with the scan acquired after 22Gy.
5.2.4 Simulation of deformations and volumetric changes
The impact of deformations and volumetric changes was simulated utilizing repeat
4D-CT scans that were acquired at 22Gy (8 patients), 44Gy (6 patients) and at
the end of the treatment 66 Gy (9 patients). In each repeat 4D-CT scan the
middle breathing phase scan was determined and used for this analysis (section
5.2.1). Delineation of these middle CT scans was performed as described in 5.2.3
above. To simulate the treatment positioning, rigid registration of the planning
CT scan with each repeat CT scan was performed. The coordinates of three
well defined anatomical points; the front node of the thyroid cartilage and the
two arytenoids were determined on both CT scans. The registration result of
the center of mass (COM) of these three points was then used to determine the
shifts applied to the iso-center of the repeat scan, followed by calculation of the
corresponding dose distribution. The applied registration method resembles our
cone beam CT based, on-line setup verification and correction protocol [92].
5.2.5 Dose calculation and plan evaluation
All dose calculations in this study were done in the Monaco treatment planning
system (Elekta/CMS software), using the integrated Monte Carlo based dose
calculation algorithm. In total 103 plans were re-calculated to simulate the
uncertainties described above. In all cases, re-calculated dose distributions
were compared with the corresponding reference distribution as designed for the
planning CT-scan (section 5.2.1 above). In all cases, the CTV was used to evaluate
tumor dose delivery; the PTV was only a geometrical tool to generate a treatment
plan. Apart from the CTV, dose in the contra-lateral vocal cord was evaluated
in detail. For the CTVs, the volume that received dose ≥ 95% of the prescribed
dose, V95%, the dose received by 98% of the structure, D98%,(near-minimum dose),
the dose received by the hottest 2% of the volume, D2%, and the generalized
equivalent uniform dose, gEUD, were calculated. The latter was computed using;
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gEUD(a) = (
∑
i=1(viDai )1/a), were a is a unit-less model parameter that has a
structure specific value, vi represents the i′th partial volume receiving dose Di in
Gy [85]. The value of the volume specific parameter for the CTV was chosen to
be (a = −13) [36]. For the contra-lateral vocal cord, the mean dose DMean, the
generalized equivalent uniform dose gEUD(a = 2.2) [100], and the percentage of
the volume that received 40Gy or more, (V40Gy), were assessed.
5.3 Results
5.3.1 CTV-delineation
Population mean CTV volume was 0.5 ± 0.1 cc, ranging from 0.2 − 0.8 cc. A
small repeat study pointed at an intra-observer uncertainty of ± 0.08 cc in vocal
cord delineation. Delineated CT volumes in the various CT-scans (pre-treatment
and repeat scans) used in this study were analyzed. It was found that, CTV
delineations for the different time points were consistent.
5.3.2 Impact of geometric perturbations on CTV dose distribu-
tions
Changes in the CTV dose parameters due to geometric perturbations are
presented in figures 5.1, 5.2, and 5.3. Averaged over all patients and shifts, changes
in the CTV V95%, D98%, D2%, and generalized equivalent uniform dose (gEUD)
compared to the reference dose distributions were 1.1 ± 2.4%, 2.7 ± 2.9%, 0.4 ±
1.4%, and 0.8 ± 1.0 Gy, respectively (figure 5.1). Largest changes were generally
observed for ’into-tissue’ lateral shifts. Even for patient 10, with lowest V95% and
D98%, the gEUD value remained above 66Gy withD98% = 89%.
Figure 5.2 shows a relatively small impact of respiration phase on CTV dose
parameters. Averaged over the 10 patients and considering both inhale and exhale
scans, V95%, D98%, D2%, and the generalized equivalent uniform dose (gEUD)
changed by 1.0 ± 2.0%, 1.9 ± 2.8%, 0.7 ± 1.0%, and 0.6 ± 0.7 Gy, respectively
(figure 5.2).
Figure 5.3 shows the impact of deformations and other volumetric changes
during the course of fractionated treatment. Apart from the 22 Gy scans of
patients 4 and 9, all deviations from the 0 Gy planning scan are minor. No clear
explanation for the larger deviations is available as there is no indication of a
change in delineated CTV (see section 5.3.1). Anyway, in all cases, the gEUD
values were larger than 67 Gy, and D98% values were never lower than 93%. For
all 22 Gy, 44 Gy and 66 Gy scans together, V95%, D98%, D2%, and the generalized
equivalent uniform dose ( gEUD) changed by 1.0 ± 1.9%, 1.9 ± 3.0%, −0.5 ±
2.8%, and 0.1 ± 1.5 Gy on average.
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Figure 5.1: Variations in CTV dose parameters with shifting the isocenter by 2 mm in
different directions. In the upper panel the percentage of the CTV volume receiving dose
of ≥ 95% of the prescribed dose is shown. The dose received by 98% of the CTV volume
, and the dose percentage received by the hottest 2% of the CTV volumes are presented
in the middle panel. In the lower panel the CTV generalized equivalent uniform dose for
each simulated situation is shown.
5.3.3 Impact of geometric perturbations on CL vocal cord
sparing
The population averages of the planned DMean, gEUD, and V40Gy as presented
with circles in figures 5.4, 5.5, and 5.6 are 38.2 ± 6.0 Gy, 43.4 ± 5.6 Gy, and 42.7
± 14.9%, respectively. As expected, the shift analyses in figure 5.4 show largest
increase of the CL vocal cord dose with iso-centric shifts towards airgap and the
contrary with shifts away from the airgap. Considering all shifts in all patients,
DMean, gEUD, and V40Gy, changed compared to planning by -0.4 ± 4.9 Gy, −0.2
± 4.7 Gy, and −1.2 ± 10.7%, respectively. Clearly, the large gain relative to a
conventional RT technique (DMean= 66 Gy, V40Gy= 100%) is maintained. Even
for the shifts giving highest parameters, there is still a considerable gain in terms
of sparing.
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Figure 5.2: Variations in the dose to the CTV in extreme inhale and exhale respiration
phases compared to average phase that was used for planning. In the upper panel the
percentage of the CTV volume receiving dose of ≥ 95% of the prescribed dose, middle
panel the dose received by 98% of the CTV volume, and the dose percentage received by
the hottest 2% of the CTV volumes are shown. In the lower panel the CTV generalized
equivalent uniform dose for each simulated situation is shown
As for the CTV, change in respiration phase resulted in the smallest changes
in dose parameters (compare figure 5.5 with figures 5.4 and 5.6). Changes in
respiration phase resulted in 1.2 ± 2.3 Gy, 1.2 ± 2.1 Gy, and 1.4 ± 5.1% changes
in DMean, gEUD, and V40Gy, respectively. For the 22 Gy, 44 Gy and 66 Gy
scans (figure 5.6), these parameters changed by −0.8 ± 3.6 Gy, −0.1 ± 3.2 Gy,
and −2.5 ± 9.3%, respectively.
In eight of nine patients with a 0 Gy CT-scan available, V40Gy after 66Gy
is higher than at planning (figure 5.6). For this reason, we studied the airgap
between the vocal cords as a function of delivered dose. For the 10 patients,
when plotting the mean airgap area as a function of the dose, the average of the
slopes of the regression lines was negative (p = 0.004), indicating that there is
an overall decrease in the airgap areas with progressing treatment time. This
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Figure 5.3: Variations in some CTV dose parameters with preceding treatment time
shown at time points 0Gy, 22Gy, 44Gy, and 66Gy for all patients.
could possibly be explained by the incidence of arytenoid edema or synechia in
the anterior commissure that are known acute RT side effects.
5.4 Discussion
We have been the first group to propose a complete systematic image-guided
procedure for the delivery of highly focused IMRT plans for single vocal cord
irradiation [93, 92, 91, 61]. The design of CTV-PTV margins for small tumors,
partially surrounded by air, is non-trivial. Based on assessed geometrical
uncertainties, in a previous study [91], we decided on the use of a 2 mm margin for
SVCI. The present analysis was performed to dosimetrically test the robustness
of the IMRT plans generated with this 2 mm margin [91]. We used the PTV
for planning and the CTV to evaluate target dose for investigated geometrical
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Figure 5.4: Variations in the mean dose (DMean), (gEUD) and (D40Gy) received by
the CL vocal cord with iso-centers shifts of 2mm in the specified directions.
variations. Dose was always recalculated using beam angles, segments, MUs,
etc. as established during treatment plan generation. Dose distributions were
(re-)calculated with Monte Carlo simulation, taking into account all real internal
inhomogeneities and surface curvatures.
Three possible sources of geometrical variation, i.e. set-up errors, respiratory
movements, and inter-fraction volumetric changes and deformation were investi-
gated. Planned IMRT dose distributions were compared with re-calculated dose
distributions for the perturbed geometries. It was found that the good CTV dose
coverage and the CL vocal cord sparing achieved in the static reference plans
were largely maintained under the influence of treatment simulated geometrical
variations. For the CTV, coverage (V95%), near-minimum dose (D98%), and
gEUD were on average reduced by 1.2%, 2.4% and 0.6 Gy, respectively. In
a few instances, the near-minimum doses, D98%, in perturbed geometries (see
figure 5.1) were around 90% of the prescribed dose, instead of 95%. These were
exceptions, and it should also be taken in mind that in the shift analyses, for each
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Figure 5.5: Variations in the mean dose (DMean), (gEUD) and (D40Gy) received by
the CL vocal cord in extreme inhale and exhale respiration phases compared to middle
breathing phase that was used for planning.
individual patient, this only occurred at maximum in 1/6 of the simulated shifts.
Moreover, with the proposed on-line protocol in place, 2 mm shifts are unlikely to
occur [92], and it is even less likely that they are systematic, i.e. repeating each
fraction. In the repeat CT analyses, a lower D98% in a patient repeat scan was
always accompanied by higher values at different time points (figure 5.3).
With the current, conventional treatment technique, local failure because of
tumor miss is virtually impossible. Based on our results obtained sofar ([93, 92,
91, 61], this paper), we believe that with daily on-line CBCT-based re-positioning,
probability of local failure with our planned IMRT dose distributions will also be
very low. However, given the discussion above, there may be some risk that it
not as low as for the conventional RT technique. Gowda et al [39] reported an
excellent 5-years local control of 93% following treatment with 50− 52.5 Gy in 16
fractions in an overall treatment time (OTT) of 21-26 days. In our current ideas
for SVCI, a total dose of 58.1 Gy may be delivered in 16 fractions, 5 fractions per
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Figure 5.6: Variations in the mean dose (DMean), (gEUD) and (D40Gy) received by
the CL vocal cord with preceding treatment time shown at time points 0Gy (planning),
22Gy, 44Gy, and 66Gy for all patients.
week, yielding a higher total dose than Gowda et al, and an EQD2Gy of 66 Gy
as in our current treatment approach, but in a shorter overall treatment time. A
default 3 mm CTV-PTV margin is considered for single vocal cord IMRT (increase
by 1 mm). A check on robustness of generated plan against potential anatomy
shifts during treatment as described in section 5.2.2 can be performed for each
individual patient prior to the start of treatment. Such a procedure may be used
to verify the initially selected default CTV-PTV margin on a per patient basis
and adapt the margins and the plan if needed, also in the context of potential
inter-patient variations in plan conformity. Van Asselen et al. [127] showed that
the amplitude of larynx movements due to swallowing may be > 1cm, but they
also demonstrated that the incidence and duration of swallowing are low for most
of the patients. Nonetheless, in a clinical protocol, swallowing during imaging
and treatment has to be minimized, e.g. by patient instruction and monitoring.
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5.5 Conclusions
This simulation study shows that with isotropic margins as small as 2 mm and
daily cone beam CT-guided repositioning, CTV dose remained generally high, and
large sparing of the contra-lateral vocal cord was maintained, when considering
realistic intra- and inter-fraction geometric variations. Occasionally observed
modest reductions in CTV dose have to be considered when deciding on a clinical
protocol.
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Abstract
Introduction: The treatment of choice for early glottic cancer is still being
debated; ultimately it relies on the functional outcome. This paper reports on a
novel sparing 4D conformal technique for single vocal cord irradiation (SVCI).
Methods and Materials: The records of 164 T1a patients with SCC of the
vocal cord, irradiated in the Erasmus MC between 2000 and 2008, were analyzed
for local control and overall survival. The quality of life was determined by
EORTC H&N35 questionnaires. Also the VHI (voice handicap index), and
the TSH (thyroid stimulating hormone) blood levels, were established. On-line
image guided SVCI, using cone beam CT and stereotactic radiation therapy (SRT)
techniques, were developed.
Results: A LC rate at five-years of 93% and a VHI of 12.7(0−63) was determined.
It appeared feasible to irradiate one vocal cord within 1 − 2 mm accuracy. This
way sparing of the contralateral (CL) vocal cord and CL normal tissues, could be
achieved.
Conclusions: Given the accuracy (1 − 2 mm) and small volume disease (CTV
limited to one vocal cord), for the use of stereotactic RT techniques SVCI with
large fraction sizes is currently being investigated in clinic. It is argued that
hypofractionated SVCI can be a competitive alternative to laser surgery.
Single vocal cord irradiation
6.1 Introduction
Of all head and neck cancers (HNCs), approximately 30 percent originates from
the larynx. In Europe, annually 52.000 patients are diagnosed with cancer of the
larynx. Local control (LC) varies, depending on the subsite and/or extent of the
disease (T-and N-stage). This paper analyzes patients with early glottic cancer
(EGC), that is, as defined by the UICC/AJCC classification system, disease
confined to one (T1a) true vocal cord [88]. Radiation therapy (RT) and carbon
dioxide endoscopic laser surgery (LS) have both proven to be effective treatment
modalities for T1a glottic cancers. A high cure rate is often cited using either one
modality. A summary of the literature by Sjogren et al. [115, 116] reported for
T1 lesions treated with RT alone a LC rate at five-years of 84% (range 78− 89%)
and an average larynx preservation rate of 93%. Same author published in 2008
on 143 T1a lesions treated by RT (70) and LS (73); a local recurrence of 21%
vs. 10% for RT and LS, respectively, was observed [115]. However, 16% of the
LS group needed additional treatment consisting of LS (4%) and/or RT (11%).
No significant difference in VHI was found for both treatment modalities [116].
Mendenhall and colleagues, reported in their review paper on T1 lesions treated
by primary RT, local control rates of 85−94%. Recently, Mendenhall [13] updated
their own results on T1, T2 glottic cancer. A five-year LC rate of 94% was reported
for T1a lesions. Also, of the 585 patients analyzed, ten (1.7%) experienced severe
or fatal complications [13]. In a summary paper by Grant et al. [41], local
control rates for transoral laser microsurgery (TLM) varied between 71% and
97% [137, 121, 119, 108, 103, 96, 79, 78, 72, 66, 57, 47, 40, 35, 28]. Cohen et
al., in a meta-analysis of non-randomized studies comparing the VHI of patients
receiving RT or LS, found the voice to be similar in both modalities (p = 0.1)
[16]. Similarly, in the most detailed retrospective study published by Loughran et
al. when using the full armamentarium of validated scoring systems for studying
vocal performance no difference was observed [67]. With regard to the quality
of voice in EGC; LS is in principle performed as a highly focussed treatment for
a clinical target volume (CTV) located on one vocal cord, while in conventional
RT, the radiation fields do not conform to the tumor volume per se but in fact
both vocal cords are irradiated. Moreover, in a number of cases LS is still to be
followed by EBRT of the larynx.
A comparative dosimetric analysis of vocal cord irradiation using different
techniques, that is conventional (box technique) vs. IMRT of the larynx vs.
single vocal cord irradiation, has recently been published by our group. This paper
focuses on the comparison of the dose distribution in many of the normal tissues at
risk, using either one of the aforementioned techniques. The reduction of potential
side effects, such as pain, poor quality of voice, speech, xerostomia, dysphagia,
incidence of stroke or transient ischemic attack following radiation of the neck,
and hypothyroidism, will be discussed. Given the fact that one is dealing with
small volume disease (CTV [part of] one vocal cord), when using SRT techniques,
the role of (hypo) fractionation can be analyzed. It is argued that single vocal cord
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irradiation by hypofractionation, considering the low probability of normal tissue
side-effects, can be a future way to treat early (T1a) glottic cancers. Good local
control rates, improvement of VHI, short overall treatment times and potential
room for retreatment with preservation of the larynx, can be anticipated.
6.2 Methods and Materials
The purpose of this paper is to report on treatment optimization when radiating
T1a vocal cord lesions. As a base line observation, first the results from our own
institution on LC, OS, quality of life (QoL) and voice handicap index (VHI) of
EGC treated with conventional radiation therapy were analyzed. For a clinical
review on LS, the reader is referred to the many papers on this issue reported
in the literature. These data have been briefly summarized in the introduction
section of this paper.
6.2.1 LC and survival using conventional radiotherapy of early
glottic tumor
To analyze the LC rate and QoL results, all records of patients with SCC of
the glottis were reviewed (figure 6.1); newly diagnosed carcinoma in situ (35
Tis), T1b lesions (38; both vocal cords) were excluded from the present analysis.
The remaining patients with SCC of the true vocal cords (164 T1a) treated
between 2000 and 2008 at our institute, were studied. All patients were simulated
in supine position; for immobilization purposes a custom made head shell was
manufactured. Lateral parallel-opposed wedged 6 MV photon beams, mean field
size ≤ 36cm2 [6×6cm2], with the iso-center placed at the center of the vocal cord
lesion, were used. One fraction per day, fraction size of 2− 2.3 Gy, was given five
days per week, up to a total dose of 60−66 Gy. The dose was prescribed according
to ICRU guidelines (with dose in the target varying between 95% and 107%) [89].
The absence of a lymphatic network and consequently the low incidence of nodal
spread do not warrant elective nodal irradiation. Patients of the current series
were analyzed for local control with or without salvage, and overall survival. Also,
QoL using the EORTC H&N35 questionnaires, the quality of voice using the VHI
(voice handicap index), and the thyroid function status (TSH [thyroid stimulating
hormone] blood levels), were determined.
6.2.2 Intensity modulated radiotherapy for T1a early glottic
cancers, single vocal cord irradiation technique
Ten patients with T1aN0M0 glottic carcinomas were previously treated at our
institute by lateral P-O fields (box technique), and were retrospectively used for
the current investigation. The conventional treatment plans were originally made
using the CadPlan treatment planning system (Varian Medical Systems, Palo
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Early Glottic Laryngeal Carcinoma 2000-2008
Tis, T1a, T1b
n= 237
T1a  n=164 
 
QoL n=89 TSH§ 
3.3%
outside range
LC/OS
93%/83%
at 5-years
VOICE HANDICAP INDEX*
VHI 12 (0 63)
EORTC H&N35*‡ 
  .7 -
VHI Functional 3.4(0-20)
VHI Physical 6.5 (0-25)
VHI Emotional 2.7 (0-21)
Swallowing 5.6 (0-92)
Dry mouth 19.6 (0-100)
Sticky saliva 17.1 (0-100)
Speech 12.7 (0-63)
P i 7 5 (0 50)
* QoL mean scores (range) based on last assesment
a n .  -
‡ EORTC H&N35 scales; mean scores(range)
§ TSH normal range 0.4-4.3
Figure 6.1: For patients treated in the Erasmus Medical Center-Daniel den Hoed Cancer
Center, figure 6.1 depicts the LC (local control) and OS (overall survival), the QoL
(quality of life) scales and VHI (voice handicap index). Also presented are the blood levels
TSH (thyroid stimulating hormone) reflecting the thyroid function post radiotherapy.
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Alto, USA), and were regenerated in the XiO treatment planning system (V 4.33
Elekta-CMS Software), using heterogeneity corrections and a fast convolution
superposition algorithm. In all planning CT scans (resolution 1mm3) the clinical
target volume (CTV, margin 3 mm) and the organs at risk (OARs) were
delineated. The delineated structures were the vocal cords, arytenoids, swallowing
muscle at the level of the vocal cords (inferior constrictor muscle, ICM), ipsi- and
contra-lateral strap muscles, carotid arteries, thyroid gland, thyroid and ricoids
cartilages, and the spinal cord. The cranial-caudal extensions of the contours
of these OARs were at the level of the vertebra C2 and C7. IMRT and SVCI
treatment planning was performed for an Elekta Synergy linear accelerator with
40 MLC leaf pairs and a leaf width at the isocenter of 4 mm (Elekta Beam
ModulatorTM, Elekta Oncology Systems, Crawley, UK) at 6-MV. The minimum
segment size allowed was 0.5cm2. The isocenter of the treatment was set to the
center of one of the vocal cords. The radiation schedule proposed to be used in
combination with the SVCI technique, is discussed in the next section.
6.3 Results and Discussion
6.3.1 Laser surgery or radiotherapy
Carbon dioxide endoscopic LS is an established treatment technique for early
glottic cancer. According to Sjogren et al. [116] LS was introduced in the Leiden
University Medical Center, for T1a midcord lesions, in 1996. The results were
summarized as follows; "T1a glottic carcinoma allocated to radiotherapy have a
poorer outcome in terms of local control and laryngectomy free survival than do
T1a patients selected for laser surgery". Motta et al. [80] assessed the vocal
function of patients who had undergone CO2 laser cordectomy. No functional
compensation enabled the patients to achieve a voice quality comparable with
that of controls. Vilaseca et al. [134] studied the voice quality after CO2 laser
cordectomy. They concluded that the voice improved in almost 60% of the
patients, returning to normal in 45%. Nunez et al. [86] analyzed functional
outcome and self-evaluation of the voice of patients with T1 glottic carcinoma
treated with endoscopic LS and RT. When comparing the VHI scores, this was
in apparent favor for RT, in functional and emotional ratings as well as for the
global scores. VHI scores of the T1a larynx cancer group after radiotherapy in
our hospital has been listed in Table 6.1.
Despite the (sometimes contradictory) reports on post-treatment voice quality,
it is mostly agreed upon that radiotherapy results in equal or even better voice
quality post treatment as opposed to LS [116]. Moreover, even better outcomes are
to be expected with the emerging more focused RT techniques (see below). Apart
from this, the comparison of LS with conventional RT techniques is not really
valid due to patient selection. For example, since patients treated for small, early
lesions are exposed more commonly to LS and, therefore, a favorable outcome for
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Table 6.1: Mean and range of the VHI-scores T1a larynx group after radiotherapy.
VHI: voice handicap index, VHI-F: VHI-functional, VHI-E: VHI-emotional, VHI-P:
VHI-physical.
VHI-total, mean (range) 12.7 (0-63)
VHI-F, mean (range) 3.4 (02-0)
VH-E, mean (range) 2.7 (0-21)
VHI-P, mean (range) 6.5 (0-25)
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Figure 6.2: An example of typical dose volume histograms (DVH) comparing the
dose received by the CTV (panel 1). Also depicted are the organs at risk when using
conventional parallel opposed beam (dotted lines) and IMRT for single cord irradiation
(solid lines).
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this patient group is anticipated. This bias can only be overcome by the design
of prospective randomized trials.
In addition to a localized tumor growth confined to one or both vocal
cords, geometrically complex tumors could also be treated with RT using IMRT
techniques and still achieve excellent normal tissue sparing. These include tumors
involving the anterior commissure (AC) which are most often not amenable for
LS. Moreover, for T2 tumors extending into to the sub- or supra-glottic regions,
so far insufficient data with regard to LS are available.
6.3.2 Single vocal cord irradiation (SVCI) with IMRT
In the Erasmus Medical Center a study was undertaken by Osman et al. on the
feasibility of unilateral vocal cord irradiation (SVCI) for T1a lesions. The concept
was to see whether unilateral vocal cord irradiation could reliably be re-produced
on a daily basis (i.e. in case of fractionated RT). In 2008, our first study was
published showing that the intra-fraction movement of the vocal cords was small
and not prohibitive for executing such a delicate treatment technique [93]. A
second publication dealt with the adequacy of daily on-line re-positioning [92].
A subsequent paper showed the superiority of IMRT as opposed to lateral P-O
irradiation techniques with regard to normal tissue involvement [91].
6.3.3 Risk of ischemic vascular side effects after neck irradiation
In recent years attention has increasingly been devoted to vascular effects when
radiation is the treatment of choice for a primary cancer in the head & neck
region [11, 104]. RT of the head and neck is found to be a significant risk factor
for carotid artery stenosis. In a paper by Brown et al. [11], an incidence of 18%
carotid artery stenosis in the ipsilateral irradiated neck vs. 7% in the contralateral
non-irradiated neck was reported. Lateral P-O portals include in part the carotid
arteries; consequentially, since one of the causes of stroke is carotid artery stenosis.
Stroke could be considered as a typical side effect associated with irradiation of the
head and neck. According to Dorrestein et al. [27], the overall risk of strokes after
RT was significantly increased compared to the general population. Rosenthal et
al. [104] concluded from a literature survey that 50 Gy could be considered the
approximate threshold dose for vascular (i.e. carotid arteries) damage in the neck
after post-irradiation. Consequently, treatment options for previously irradiated
patients (with conventional RT methods) are potentially limited due because of
increased risk for carotid injury. In our planning study using SVCI techniques with
IMRT, no part of the carotid arteries received doses as high as 50 Gy (see mean
and maximum dose received by the carotid arteries Table 6.2). Therefore, this
might allow for re-irradiation of these tumors. In conclusion, additional treatment
options for recurrent tumors or second primary tumors in the upper aerodigestive
track are another benefit for using IMRT. These tumors are usually salvaged with
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surgery with very generous surgical margins (e.g. by laryngectomy), obviously
negating the effect on the QoL of these patients.
Table 6.2: Mean dose to PTV, CTV and critical structures. IL = ipsi-lateral, CL,
contra-lateral.
SVCI BVCI PO
Dose (Gy) with with clinical
IMRT IMRT plans
PTV Mean± SD 67± 1 67± 1 67± 1
CTV Mean± SD 67± 1 67± 1 67± 1
CL vocal cord Mean± SD 39± 8 (n.a.) 67± 1
IL arytenoid Mean± SD 64± 3 65± 1 66± 1
CL arytenoid Mean± SD 20± 8 66± 2 66± 1
ICM Mean± SD 28± 4 39± 5 61± 3
IL strap muscle Mean± SD 17± 2 18± 3 49± 8
CL strap muscle Mean± SD 9± 4 18± 3 49± 10
Thyroid gland Mean± SD 3± 1 3± 1 17± 11
Thyroid gland Max± SD 10± 8 10± 9 15± 11
Thyroid cartilage Mean± SD 28± 5 38± 7 66± 1
Cricoid Mean± SD 22± 4 28± 4 61± 4
IL carotid artery Max± SD 24± 5 31± 4 66± 3
CL carotid artery Max± SD 12± 2 30± 5 66± 2
Spinal cord Max± SD 22± 10 27± 6 2± 0
6.3.4 Hypothyroidism
Hypothyroidism remains an underreported and often under-appreciated late
sequel of RT or thyroid surgery [34]. Early recognition and suppletion with thyroid
hormones may prevent the development of clinical symptoms of hypothyroidism.
In the laboratory of the Erasmus MC, TSH normal values range from 0-4.3
mUnits. In the patients under investigation, a maximum of 6% had abnormal
values of TSH (that is outside the normal range), see also figure 6.1. This low
number is probably due to the anatomical position of the thyroid gland. Thus,
a small dose is apparently to be received by the thyroid glands with normal
anatomical positioning (see Table 6.2 in general). However, a simple TSH routine
check in follow-up is still worthwhile for picking up these isolated cases (6%). A
detailed analysis of hypothyroidism is beyond the scope of the present paper.
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(A)SVCI-IMRT (B)TVCI-IMRT (C) Conventional PO
Figure 6.3: Transverse (top), coronal (middle), sagittal (bottom) slices showing typical
dose distributions (iso-dose fill) obtained using IMRT for the right vocal cord (first
column), IMRT for both vocal cords (second column), and P-O plans (third column).
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6.3.5 Radiotherapy for the management of early glottic tumors
A comparison of the dose received by the various structures from the different
radiotherapy techniques is shown in [figure 6.2] and [figure 6.3]. In figure
6.2 examples of typical dose-volume-histogram (DVH) comparisons are shown,
illustrating the dose received by the vocal cords, arytenoids, inferior constrictor
muscle (ICM), spinal cord, strap muscles, and the arytenoids when using lateral
P-O wedged photon beams (dotted lines), IMRT for two vocal cords (dashed lines)
vs. IMRT for a single vocal cord (solid lines). In the lateral P-O beam plans most
of the structures receive the full dose as opposed to IMRT plans, where notable
sparing of normal tissue is obtained (also see Table 6.2). figure 6.3 shows examples
of three dose distributions; column (A) for SVCI with IMRT for a T1a tumor on
the right vocal cord. In addition, in column B, an example of a T1b-IMRT plan
is shown for both vocal cords. Finally, column C, a typical dose distribution
for lateral P-O beams is presented. At present accurate treatment techniques
are available to apply highly focused radiation, e.g. with the use of cone beam
CT and stereotactic radiation. Given the small target and the large amount of
sparing of different normal tissues, apparently the CTV and PTV margin can be
small and the benefit of hypofractionation becomes an issue. We have, therefore,
proposed to start a clinical pilot study using five fractions of 8.5 Gy per fraction,
with the dose prescribed to the 80% isodose line. Finally, we have not discussed
the issue of costs per treatment modality since they differ substantially given the
variations in health care providers (national guidelines) per country.
6.4 Conclusions
Treatment modalities of T1 vocal cord lesions differ substantially per institution.
Many of the selection factors involved were evaluated in this study in order to
arrive at the best treatment option. The analyzed selection factors were LC, OS,
QoL, preservation of voice, potential for vascular side effects, and hypothyroidism.
The weight given to each of the QoL factors and the potential side effects of
LS will guide the preference for either LS or RT. The outcome in QoL and the
preservation of voice have, in general, favorably been reported for RT; this is
despite the fact the RT involves a larger surface area than is the case with LS (i.e.
two vocal cords in stead of one). Vascular side effects and hypothyroidism are not
present when using LS. The risk for the occurrence of these side effects is, however,
extremely small in the case of RT and can be further reduced by using advanced
RT techniques, such as IMRT and SVCI. For good reasons (see paragraph before),
it has been argued to start the clinical testing of the role of hypofractionation in
these very small target volumes. Finally, of obvious advantage is the fact that
RT is a non-invasive technique. However, in terms of evidence based medicine,
randomized trials for the outcome of SVCI by IMRT techniques and LS are absent
but are definitely needed in order to make a more balanced comparison for these
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competitive techniques.
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General Discussion
7.1 Radiotherapy for early stage glottic tumors
The treatment of early stage glottic cancers is still widely debated because there
are many effective treatment modalities that are equally successful in terms
of local control. The most common choices are radiotherapy and endoscopic
laser surgery that have very comparable outcomes. Therefore, besides cure
the choice between treatment modalities should rely on laryngeal preservation,
voice preservation, minimal morbidity, expense and convenience (i.e. patient’s
preference).
Despite the increased popularity of endoscopic laser surgery in recent years,
many still consider radiotherapy to be the treatment of choice. This is because
patients treated with radiotherapy are reported to have superior voice quality
as opposed to those treated with laser surgery [86, 59]. This conclusion is
supported by quantitative acoustic measurements, auditive perception (perceived
voice quality) and more importantly patient self evaluation voice handicap index
(VHI) questionnaires. This VHI questionnaire reviews situations grouped into
three areas (functional, physiological and emotional) and gives an idea of the
subjective impact that a vocal problem produces in a specific individual [23].
Additionally, in contrast with laser surgery, practically all types of early glottic
tumors can be treated with RT. In conventional radiotherapy, parallel opposed
wedged photon beams are generally used to cover the tumor and the surrounding
healthy structures conservatively. With this conventional treatment technique the
tumor as well as all laryngeal structures receive the total prescribed dose (e.g. 66
Gy in 33 fractions of Gy at our institute). This is a well established treatment
technique with excellent results. Nevertheless, this treatment technique could be
optimized further by sparing healthy structures that are unnecessarily irradiated.
This has the potential of reducing radiotherapy related side effects for this group
of patients.
Moreover, despite the very good outcome of this treatment, recurrent tumors
are encountered. One reason could be that many patients do not quit smoking
after the treatment for the initial tumor [128]. Another reason might stem from
technical pitfalls of the conventional radiotherapy settings. Among these, the
most commonly discussed limitation is the underdosage due to inadequate build-
up of electrons [53, 94, 120]. This problem is unrealized by most of commercially
available treatment planning systems (TPS) due to accuracy limitations of their
dose calculation engines [53, 132]. The problem is more pronounced for tumors
that lie close to the anterior skin and also on the surface of the air cavity in the
interior of the larynx. This could possibly also explain why anterior commissure
involvement is associated with inferior local control as reported by a number of
authors [70, 87]. Inadequate build-up of electrons may be found beneath the skin
of the neck as the anterior commissure is only 1cm from the skin, resulting in
underdosing of these regions. Patients with recurrent tumors are usually referred
to surgery and not infrequently a laryngectomy is performed which has a negative
impact on the quality of life of these patients. Another technical difficulty that
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conventional RT techniques are faced with is treating patients with short necks,
which makes the use of lateral opposed fields troublesome. In such cases oblique
fields are used leading to more spread of the high dose regions to other OAR.
In addition to the technical challenges there also exist some clinical problems.
These problems are directly linked to delivering high doses to healthy tissues.
Among these problems, voice/speech impairment, persistent edema of the
arytenoids, the increased risk of xerostomia, trismus, strokes and hypothyroidism.
This topic is discussed in greater detail in chapter 6.
There have been some attempts in the past to reduce the dose received by the
arytenoids to prevent persistent edema of the arytenoids [4]. Recently, some
institutes have incorporated intensity modulated radiotherapy (IMRT) in the
treatment of early glottic cancers [104, 14]. Their main goal was to spare the
carotid arteries in an attempt to reduce the risk of stroke in this group of patients.
However, given the excellent results of a conventional technique, some people have
been reluctant and stood against the use of small treatment fields and IMRT for
these patients, as the use of small fields could increase the risk of a geographic miss
[31]. Moreover, as a result of limitations of dose calculation algorithms, problems
of underedosage at the air-tissue interface and at the anterior commissure might
remain undetected without the use of advanced dose calculation engines. These
technical concerns were taken into account in the studies described in this thesis.
In this thesis we have presented a novel radiotherapy procedure to treat
patients with early glottic tumors with highly conformal dose distributions. In
chapters 2−5, single vocal cord irradiation with IMRT is presented as a potential
solution for limitations of conventional RT techniques mentioned above. Because
of the availability of an advanced treatment planning system with a Monte Carlo
(MC) dose calculation engine, also for smaller treatment fields with air around
the tumor, good estimates of the of the delivered tumor dose can be obtained.
From the dosimetric point of view, this allowed the introduction of small field
treatments. All treatment steps are conducted with caution to ensure the high
precision that is crucial for this treatment technique. We have employed 4D-CT to
monitor and quantify patient respiration correlated movement of the tumor [93].
Cone beam CT scans were investigated for daily positioning of the patients with
high accuracy [92]. The studies pointed at possibilities for tremendous sparing
of OAR. This has the potential of reducing RT related side effects while still
maintaining the good local controls achieved by conventional RT techniques.
Moreover, limiting the dose to normal structures might increase treatment
options for patients with recurrent tumors or second primary tumors, especially
in younger patients. In chapter 6, we have presented SVCI as a competitive
treatment technique to conventional RT as well as to laser surgery. We have also
presented some of our own institutional results on quality of life of early glottic
cancer patients and we related our results to those published for laser surgery.
It is important to realize that the studies in this thesis pointing at good
possibilities for focused radiotherapy were done in a retrospective setting, no
patients were treated with IMRT. All involved CT datasets were acquired for
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patients treated with the conventional technique. Also, the number of studied
patients was low. Therefore, caution is needed in clinical introduction.
7.2 A clinical protocol
So far, five early glottic patients have been entered into a clinical protocol for
highly focused IMRT. Here, some details are briefly discussed.
7.2.1 CTV delineation and CTV-PTV margin
CTVs are delineated on a pre-treatment contrast-enhanced planning CT scan
with the aid of an endoscopic photograph of the patient’s vocal cords. In this
process, the central axial CT slice of the vocal cords is fused with the endoscopic
photograph of the patient’s vocal cords. Goal is to delineate at least the volume
that would have been surgically resected if the patient was referred to endoscopic
laser surgery rather than radiotherapy. If only the CT scan is used for tumor
delineation, it is of great difficulty to define the borders of the CTV. For extra
safety, three millimeter isotropic margins are used for CTV-PTV extension instead
of the 2 mm mentioned in chapters 4 and 5. A study evaluating inclusion of MR
images to further enhance tumor delineation accuracy is being discussed.
7.2.2 Dose fractionation and overall treatment time (OTT)
Reducing the overall treatment time could reduce the re-population of tumor
cells between sessions and result in better tumor control. On the other hand,
the main concern against less fractions and so increased dose per fraction is the
risk of increased toxicity. The subject of clinical outcomes of altered fractionation
schemes in early glottic cancer has been investigated by a number of groups [39,
90, 9]. Nevertheless, it is difficult to distinguish the effect of dose per fraction
and overall treatment time (OTT) from these studies as most of them alter both
parameters. Gowda et. al. [39] reported an excellent 5-year LC of 93% following
treatment with 50− 52.5 Gy in 16 fractions and an OTT of 21-26 days.
As our dose distributions for single vocal cord IMRT are really focused
compared to conventional treatment (Chapter 4), the enhanced toxicity risk
following a moderate OTT reduction is expected to be compensated. In our
current protocol, a total dose of 58.08 Gy is delivered in 16 fractions (fraction
dose d = 3.63 Gy), 5 fractions are delivered per week. Using the linear-quadratic
model, the biological equivalent dose given in fractions of 2 Gy (EQD2Gy) is given
by EQD2Gy = D ∗ [α/β + d]/[α/β + 2], where α/β is the alpha-beta ratio in Gy
and d is the dose per fraction. In the selected scheme EQD2Gy = 66 Gy for the
tumor (using α/β = 10 Gy), which is identical to the total dose we are used to
give in non-IMRT larynx treatments.
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7.2.3 Daily image-guidance
To minimize tumor miss probability and monitor adequate dose delivery, three
daily cone beam CT scans are made. The first is used to re-position the patient,
aiming at the set-up as established during planning. The second is acquired
immediately after re-positioning to check proper execution of the required set-
up correction. The third scan is acquired after delivery of all treatment beams
(around 10 minutes after switching on the first beam).
Adaptive radiotherapy (ART) is an approach to correct for non-rigid anatomi-
cal changes during fractionated treatment through on-line or off-line modification
of the original IMRT treatment plan, based on acquired images. Many groups
have demonstrated the potential benefit of using ART in the treatment of head
and neck cancers with IMRT [12, 49, 2]. In chapter 5 we have shown that the
impact of anatomy deformations on delivered dose in single vocal cord IMRT
may be limited. However, there was also evidence for time trends in the air gap
between the vocal cords. Possibly, the daily acquired CBCT could be used to
further study the potential role of ART in single vocal cord IMRT. The CBCT
might even be useful in adapting the treatment plans if needed [25, 58, 44, 64, 131].
7.3 Swallowing during imaging and treatment
It is known that the displacement of the larynx due to swallowing is large. Van
Asselen et al. [127] showed that the amplitude of the larynx movements is > 1cm,
but they also demonstrated that the incidence and duration of swallowing are low
for most of the patients. In our protocol, patients are instructed not to swallow
during image acquisition as well as during treatment delivery. We also instruct
them to give a signal if they can not avoid swallowing at any moment.
7.4 Non-coplanar treatment set-ups
Chapter 4 includes a preliminary study on the of use of non-coplanar vs coplanar
optimized beam angles. Because of the involved couch rotations, non-coplanar
treatments at a linear accelerator are time-consuming. Moreover, the couch
rotations might also comprise treatment accuracy. The Cyberknife (Accuray)
has the interesting option to irradiate patients with non-coplanar beams without
the need for couch rotations. It would be of interest to investigate plan quality
with this system, compared to coplanar treatment on a conventional linac. Part of
the investigations should focus on the accuracy of tumor set-up using planar kV-
images as obtained with the Cyberknife system. Possibly, the Cyberknife could
also be upgraded with 3D/4D imaging facilities.
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Summary
An early stage glotic cancer can effectively be treated using RT alone, showing
excellent results (80 − 90% probability of cure). Conventionally, for the RT
treatment, tumors are irradiated using two parallel opposed wedged photon beams
(typical field size 25 − 50cm2 ). A conservative approach is used where the
fields generously cover the tumor and surrounding healthy structures are greatly
involved. Among the structures that are unnecessarily irradiated ; the contra-
lateral vocal cord, arytenoids, swallowing muscles and carotid arteries at the level
of the vocal cords. This might give rise to complaints such as; impaired voice,
persistent arytenoid edema, dysphagia, and increased risk of strokes. Evidence
was found of an inverse relationship between the dose to the laryngeal structures
and quality of life (QoL) indicators concerning e.g., speech, diet. This highlights
the need for a more optimized focused RT technique. Moreover, as early stage
glottic tumors are known to be very localized and limited to the mucosa with no
lymphatic vessels involvement this promotes the use a more localized technique
for treatment. Therefore, we have been developing a technique for highly
focused vocal cord irradiation in early glottic carcinoma, namely single vocal cord
irradiation (SVCI) with intensity-modulated RT (IMRT). This technique aims at
optimally treating a target volume confined to a single cord while sparing the
surrounding healthy structures as much as possible. An overview of the steps
involved in the development of this image-guided radiotherapy (IGRT) technique,
are presented in this thesis.
In chapter 1 of this thesis a general introduction to the anatomy of the larynx
and the conventional RT techniques used in the management of early stage glottic
cancers is given.
As a first step in realizing SVCI, 4D-CT were used to assess respiratory vocal
cord motion as described in chapter 2 . Nine discrete phase-resolved CT scans
were reconstructed for each patient . Movement of the vocal cords with breathing
were quantified using the 4D-CT data. Maximum displacements of the vocal
cords were observed in the lateral direction towards the back of the larynx. The
patient-averaged standard deviation (SD) with breathing here was 1.3mm while
the corresponding average lateral air gap width was 11mm. It was concluded that
vocal cords movements due to breathing are generally small. Therefore, breathing
motion does not seem to be a limiting factor for SVCI. In the preparatory phase for
the treatment a 4D-CT should be acquired for each patient, using the methods
described in chapter 2. Based on this 4D-CT scan, the average anatomy and
deformation due to breathing motion could be monitored on an individual basis
to identify any outliers. If a mid-phase CT scan is used for planning this can
rule out intra-fraction systematic errors. In this case, the clinical target volumes
(CTV) will be expanded with margins to take into account only the small residue
random errors.
In daily treatment execution, highly focused SVCI requires sub-mm daily
targeting accuracy to be effective. In chapter 3, a protocol for daily positioning
corrections with on-line kV-cone beam CT (CBCT) is presented. From the
statistics of the population under study, the residue systematic and random set-
up errors (after using this on-line correction procedure) were measured and used
to derive the safety margins required to expand the CTV volumes. While before
correction the systematic displacements of the vocal cords were as large as 2.4 ±
3.3mm (cranial-caudal population mean ± SD Σ), daily CBCT registration and
correction reduced these values to less than 0.2± 0.5mm in all directions. Random
positioning errors (SDσ) were reduced to less than 1mm. The added imaging dose
(approximately 1mGy per scan) from each CBCT scan was negligible compared
to the treatment dose. In conclusion, on-line registration and correction using
available CBCT acquisition and registration software can yield sub-mm systematic
and random displacements for the vocal cords when combined with standard
mask fixation. Thus, the high positioning accuracy required for single vocal
cord irradiation may be achieved in a clinically feasible procedure. Estimated
safety margins required to account for inter-fraction as well as intra-fractional
set-up variations are small enough to spare the healthy vocal cord (<2mm in all
directions).
Image-guided SVCI using IMRT is presented in chapter 4. An in-house
IMRT/beam angle optimization algorithm was used to obtain coplanar and non-
coplanar optimized beam angles. Using these angles, IMRT plans targeting a
single vocal cord were generated. For the sake of comparison, conventional
treatment plans using two laterally opposed wedged 6-MV photon beams are
also presented. The tumor dose coverage and dose delivered to the OARs using
conventional parallel opposed fields, IMRT using computer-optimized coplanar
and non-coplanar beam setups are compared. The dose calculations were
performed using a Monte Carlo (MC)-based treatment planning system (TPS).
In conventional plans as well as in IMRT plans, the population-averaged mean
tumor dose ± standard deviation to the planning target volume was 67 ± 1Gy.
The contra-lateral vocal cord dose was reduced from 66 ± 1Gy in the conventional
plans to 39 ± 8Gy and 36 ± 6Gy in the coplanar and non-coplanar IMRT plans,
respectively. IMRT consistently reduced the doses to the other organs at risk. In
conclusion, evidence was found that image-guided SVCI using IMRT can provide
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significant sparing of critical structures without compromising CTV coverage.
This might also allow re-irradiation (if the need arises because of second primaries
in the vicinity), especially in younger patients. In this study (chapter 4) we
also presented a class solution of beam angles to ease and standardize the IMRT
treatment planning for a single vocal cord.
It is known that the increasingly conformal dose distributions provided
by intensity modulated radiotherapy (IMRT) can be sensitive to geometrical
treatment uncertainties. In chapter 5 we have conducted a study to test the
sensitivity of single vocal cord IMRT treatment plans to set-up errors, respiration,
and deformation. Pre-treatment 4D-CT scans were used for IMRT planning,
generating the reference dose distribution. The impact of set-up errors was
simulated by applying shifts to the planning CT-scans, followed by dose re-
calculation with original beam segments, MUs, etc. Effects of respiration and
deformation were determined with inhale and exhale CT-scans, and repeat scans
acquired after 22Gy, 44Gy, and 66Gy, respectively. This simulation study shows
that with isotropic margins as small as 2mm and daily cone beam CT-guided
repositioning, CTV dose remained high, and large sparing of the contra-lateral
vocal cord was maintained, when considering realistic intra- and inter-fraction
geometric variations.
In chapter 6, SVCI as a competitive treatment strategy for early glottic
cancer is presented. Given the very comparable outcome of conventional RT
and laser surgery (LS) in the management of early glottic tumors in terms of
cure, the treatment of choice ultimately relies on the functional outcome. The
outcome in QoL and the preservation of voice have, in general, favorably been
reported for RT despite the fact the RT involves a larger surface area than is
the case with LS (i.e. two vocal cords instead of one). SVCI using IMRT in
combination with hypo-fractionation is also discussed in chapter 6. Good local
control rates, improved voice, short overall treatment times and potential room for
re-treatment with preservation of the larynx, can be anticipated. It is therefore
argued that hypo-fractionated SVCI can be a competitive alternative to laser
surgery. However, It is concluded that in terms of evidence based medicine,
randomized trials for the outcome of SVCI with IMRT techniques and LS are
absent but are definitely needed in order to make a more balanced comparison
for these competing techniques.
In chapter 7, a general discussion of the topics presented in this thesis is
given. The potential benefits of using SVCI with IMRT in the management of
early stage glottic cancers is stressed. In chapter 7 we also present our early
clinical experience of treating patient using the SVCI with IMRT technique as
described in this thesis.
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Een vroeg stadium glottische kanker (vroeg ontdekte stembandkanker) kan
effectief met radiotherapie worden behandeld en geeft een uitstekende kans
op genezing van 80-90%. Voor de conventionele Radiotherapie (RT) techniek
die gebruikt wordt om deze tumoren te bestralen, maakt men gebruik van
parallelle tegengestelde, wigvormige, fotonbundels (typische veldgrootte 25-50
cm2). De behandeling is conservatief van opzet waarbij de velden de tumor
ruim afdekken maar waarbij ook veel gezond weefsel wordt meebestraald.
De kritieke structuren die onnodig worden bestraald zijn onder andere: de
contra–laterale stembanden, de arytnoid (bekerkraakbeentjes), slikspieren en de
carotid arteriën (de halsslagader). Ten gevolgen hiervan kunnen klachten zoals:
stem beschadiging, aanhoudend arytenoid oedeem, trismus en verhoogde risico
op een hartaanval onstaan. Er is een omgekeerd verband aangetoond tussen
de dosering van de laryngeal structuren en de kwaliteit van leven betreffende
stem- en eetfuncties. Dit stelt duidelijk de behoefte aan een nauwkeurige
geoptimaliseerde RT techniek. Voorts is bekend dat vroeg stadium glottische
tumoren zeer gelokaliseerd zijn, waarbij wél het slijmvlies maar niet de lymfevaten
zijn aangetast. Het gebruik van een meer gelokaliseerde behandeltechniek
zou daarom grote voordelen kunnen hebben. Voor het veilig en nauwkeurig
bestralen van vroeg stadium glottische kanker streeft men naar zo klein mogelijk
positioneringfouten, waarbij intra- en inter-fractiefouten zoveel mogelijk beperkt
worden. Voor dit onderzoek is een techniek ontwikkeld voor gerichte bestraling
van vroeg stadium glottische tumoren, waarbij slechts één stemband wordt
bestraald (single vocal cord irradiation, SVCI) met intensiteit -gemoduleerde
radiotherapie (IMRT). Deze techniek heeft als doel om de stemband optimaal
te bestralen, zodanig dat omliggend gezond weefsel zo min mogelijk wordt
beschadigd. De ontwikkeling van deze beeldgestuurde gerichte radiotherapie
techniek (Image Guided Radiotherapy, IGRT) vormt het onderwerp van dit
proefschrift en is samengevat in onderstaande paragrafen.
Hoofdstuk 1 is een introductie in de anatomie van het layrnx (strottenhoofd),
waarbij de conventionele radiotherapie (RT) techniek voor de behandeling van
vroeg stadium glottische kanker word beschreven.
In hoofdstuk 2 wordt een eerste stap voor het realiseren van de SVCI
techniek beschreven, die van 4DCT gebruikt maakt om ademhalingsbewegingen te
beoordelen. Voor elke patiënt werden CT- beelden in negen fasen geconstrueerd.
De respiratoire beweging werd aan de hand van deze 4DCT data vastgesteld. De
maximale verschuiving van de stembanden werd vastgesteld in de laterale richting,
aan de achterkant van het layrnx. Hierbij bedroeg de gemiddelde standaard
deviatie van de populatie aan patiënten 1.3 mm, met een overeenkomstige
gemiddelde breedte van de luchtspleet van 11 mm. Er werd gesteld dat
stembandbewegingen door ademhaling in het algemeen klein waren en geen
beperkende factor voor SVCI vormden.
In de voorbereidende fase van de behandeling wordt een 4D-CT van elke
patiënt gemaakt, volgens de methoden die in hoofdstuk 2 zijn beschreven. Per
patiënt kon zo een gemiddelde anatomie en vervorming door ademhaling gemeten
worden en uitzonderlijke afwijkingen worden vastgesteld. Met het gebruik van
een middenfase CT-scan voor dosisplanning kunnen intra-fractie-systematische
fouten voorkomen worden. Het klinisch doelvolume (Clinical Target Volume,
CTV) wordt dan uitgebreid met geometrische marges die slechts deze residu fouten
zullen afdekken.
Voor een effectief dagelijks klinisch gebruik vereist de zeer gerichte SVCI
techniek een submillimeter precisie. In hoofdstuk 3 wordt een protocol om-
schreven, waarbij met behulp van CT op het bestralingstoestel (cone-beam CT,
CBCT), dagelijks de patiëntpositie wordt gecorrigeerd (on-line protocol). Van
de populatiestatistieken werden systematische en random residufouten afgeleid
(na toepassing van de dagelijkse correctie) en de noodzakelijke CTV marges
bepaald. Waar vóór correctie de systematische verschuivingen van de stembanden
nog 2.4 ± 3.3 mm (cranial-caudal population mean ±SD, Σ) bedroegen, met
een dagelijkse CBCT correctie werden deze verminderd tot 0.2 ± 0.5 mm in
alle richtingen. Random positioneringsfouten (SD, σ) werden verminderd tot
1 mm. De extra dosis ten gevolge van het maken van afbeeldingen (ongeveer
1 mGy per scan) was verwaarloosbaar ten opzichte van de behandeldosis.
Gesteld kan worden dat het on-line registreren en corrigeren met behulp van
CBCT en bijbehorende registratiesoftware resulteert in submillimeter random en
systematische verschuivingen van de stembanden in combinatie met een standaard
masker voor fixatie. Deze hoge nauwkeurigheid, die vereist is voor het bestralen
van één stemband, kan onder klinische omstandigheden worden gehaald. De
geschatte geometrische veiligheidsmarges, noodzakelijk voor het ondervangen van
inter- en intra-fractie-positioneringsvariatie, zijn klein genoeg (< 2 mm in alle
richtingen) om de gezonde stemband nog te kunnen sparen.
In hoofdstuk 4 wordt beeldgestuurde SVCI met IMRT behandeld. Een in eigen
beheer ontwikkeld IMRT bundelhoekoptimalisatie algorithme werd gebruikt om
optimale coplanaire en niet-coplanaire bundelhoeken te verkrijgen. De hoeken
werden gebruikt om IMRT plannen te construeren voor één stemband. Ter
vergelijking werden ook conventionele behandelplannen met wigvormige 6 MV
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fotonbundels beschouwd. We vergeleken de tumordosering en de dosering van
kritieke organen van de conventioneel parallel tegengestelde bundels met die van
computergeoptimaliseerde coplanaire en niet coplanaire bundelplaatsingen met in-
tensiteitsgemoduleerde bundelprofielen. De dosisberekeningen werden uitgevoerd
in een Monte-Carlo-gebaseerd (MC) dosisplanningssysteem (Treatment Planning
System, TPS). Voor zowel de conventionele als voor de IMRT plannen, was de
gemiddelde tumordosis, gemiddeld over de populatie (±SD) 67 ± 1 Gy. De dosis
in de contralaterale stemband werd teruggebracht van 66±1Gy in de conventionele
plannen tot 39 ± 8 Gy en 36 ± 6 Gy bij de coplanaire en niet-coplanaire IMRT
plannen. IMRT gaf consequent een vermindering in dosis in kritieke organen.
We concludeerden dat beeldgestuurde SVCI met IMRT een significante bijdrage
kan leveren aan het sparen van gezonde weefsels zonder daarbij CTV dekking
op te offeren. Ook opent dit de mogelijkheid tot herbestraling voor de jongere
patiënt (mocht dit noodzakelijk zijn in verband met secundaire primaire tumoren
in de omgeving). In dit onderzoek (Hoofdstuk 4) presenteren we tevens een
klasseoplossing van bundelhoeken met als doel de IMRT behandeling voor één
stemband te standaardiseren.
Het is bekend dat de hoge conformiteit, die kenmerkend is voor IMRT behan-
delingen, erg gevoelig is voor geometrische onzekerheid tijdens een behandeling. In
hoofdstuk 5 hebben we de gevoeligheid van IMRT plannen voor positioneringsfou-
ten, ademhaling en vervorming onderzocht. Een 4DCT beelden die voorafgaand
aan de behandeling werd gemaakt, werd gebruikt voor constructie van het IMRT
dosisplan dat als referentie diende. De invloed van positioneringsfouten werd
gesimuleerd door het toepassen van verschuivingen in de CT scans voor planning,
gevolgd door een herberekening met originele bundelsegmenten, monitoreenheden,
etc. De effecten van ademhaling en vervorming werden afgeleid uit de CT-scans
bij in- en uitgeademde toestand, en vervolgscans na 22 Gy, 44 Gy en 66 Gy.
Deze simulatie toont, dat bij beschouwing van realistische intra- en interfractie
geometrische variaties, het gebruik van 2 mm isotrope marges in combinatie met
CBCT-gestuurde repositionering, handhaving van de CTV dosis en sparing van
de contralaterale stemband toelaat.
Hoofdstuk 6 introduceert SVCI als een concurrerende kandidaat voor de
behandeling van vroeg glottische kanker. Gegeven de zeer vergelijkbare uit-
komsten van conventionele RT en laser chirurgie (LS), wanneer het aankomt op
genezing van vroeg glottische kanker, zal de uiteindelijke keuze afhangen van
de functionele uitkomst. Uitkomsten in termen van QoL en het behoud van
de stemfunctie pleiten in het algemeen voor RT, ondanks het feit dat RT een
groter oppervlak bestrijkt dan LS (twee stembanden in plaats van één). Met het
gebruik van hypogefractioneerde SVCI met IMRT wordt een verbetering in het
stemgebruik, een korte behandeltijd en de mogelijkheid tot herbehandeling met
sparing van de larynx voorzien. We pleiten dan ook voor hypogefractioneerde
SVCI als concurrerende kandidaat voor LS. Desalniettemin ontbreekt het aan
gerandomiseerde onderzoeken voor het vergelijk tussen SVCI met IMRT en LS
technieken, hetgeen noodzakelijk is voor een juiste afweging tussen deze twee
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kandidaten.
Hoofdstuk 7 geeft een overzicht van de onderwerpen in dit proefschrift met
een nadruk op de mogelijke voordelen van SVCI met IMRT in het beheersen van
vroeg glottische kanker. Ook presenteren we de eerste klinische resultaten van de
behandeling van een patiënt met de SVCI-IMRT techniek die beschreven is in dit
proefschrift.
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